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Summary: 
  The conditional gene expression system controlled by the tetracycline-
responsive trans-activator (tTA) in transgenic mice is an important and well char-
acterized genetic tool. In my studies I investigated the function of the Tet-
regulated genes in the brain when inserted into the chromosome and when ap-
plied as extra-chromosomal elements with recombinant Adeno-Associated Virus 
(rAAV). 
    First, the pool of tTA expressing mouse lines was increased by generating eight 
functional itTA-expressing TgThy-1.2(xx)-itTAnls transgenic mouse lines. Since for tTA 
expression the Thy-1.2 promoter was used, which is known to be highly 
integration-site dependent, lines  were obtained which all differed in tTA expres-
sion level, expression pattern and ontogenetic profile in the central nervous sys-
tem (CNS). These mice are a valuable tool for studies on physiological functions 
of different neuron populations during various developmental stages. 
  Second, the effect of the chromosomal insertion site of Tet-responder genes on 
their expression was analyzed. In three different Tet-responder mouse lines, the 
precise integration sites and copy number of tet-responder genes were deter-
mined. No correlation between copy number of the Tet-responder gene and its 
expression was detected, supporting the finding that the chromosomal insertion 
site has strong effects  on the expression of the transgene. Strong Tet-responder 
gene expression was observed in mice of the transgenic line SA87.5, which has 
three copies of a transgene inserted in the Pik3c3 gene locus. By retargeting the 
same position of the Pik3c3 gene locus in embryonic stem cells, only one copy of 
the transgene was introduced. However, due to the presence of the neo selection 
marker the single Tet-responsive transgene showed poor induction by tTA. After 
Cre-virus mediated neo removal, the expression of the Tet-responsive transgene 
was improved.
  The limitations  of chromosomally inserted Tet-regulated gene elements  can be 
overcome by using the recombinant Adeno-Associated virus  (rAAV) mediated 
gene delivery system to introduce the different elements  of the Tet-system into the 
CNS. It is shown that both Tet-activators and Tet-responder genes are functionally 
delivered by rAAV vectors, and tissue specific, homogeneous, rapid and robust 
expression of multiple proteins simultaneously controlled by tTA in rAAV infected 
CNS areas can be achieved.  
   Moreover these viruses were used to demonstrate that the transcriptionally in-
active Tet-responder genes are often epigenetically silenced during development 
when inserted into the host chromosome, but remain inducible when introduced 
extra-chromosomally after development.
Zusammenfassung: 
   Das konditionale Genexpressionssystem basierend auf dem Tetracyclin ges-
teuerten Transaktivator (tetracycline-responsive trans-activator tTA) ist ein wichti-
ger und gut charakterisierter genetischer Schalter in transgenen Mäusen. In der 
vorliegenden Arbeit untersuchte ich die Funktion tTA regulierter Gene, die sowohl 
als chromosomale Integrate als auch in transienter Form durch rekombinante 
Adeno-assoziierte Viren (rAAV) im Maushirn zur Expression gebracht wurden. 
   Erstens wurde die Sammlung tTA exprimierender Mauslinien durch acht itTA 
exprimierende Mauslinien TgThy-1.2(xx)-itTAnls ergänzt. Da zur tTA Expression der 
Thy-1.2 Promoter, dessen Aktivität durch die Integartionsstelle stark beeinflusst 
wird, benutzt wurde, unterscheiden sich diese Mauslinien in Expressionsstaerke, 
Expressionsmuster und im ontogenetischen Profil. Diese tTA Mauslinien stellen 
ein wertvolles  Wekzeug für physiologische Studien der Funktionen unterschiedli-
cher Neuronenpopulationen während verschiedener Entwicklungsstadien im 
Maushirn dar.
   Zweitens wurde der Einfluß der chromosomalen Integartionsstelle für tTA kon-
trollierte Gene untersucht. In drei verschiedenen Mauslinien mit TA abhängigen 
Genen wurde der genaue Integrationsort sowie die Anzahl von Kopien des 
Transgens bestimmt. Dabei konnte kein Zusammhang von Kopienzahl des 
Transgens und dessen Expressionsstärke nachgewiesen werden. Dies kann als 
Hinweis auf den starken Einfluß des Integartionsorts für die Expressionsstärke 
tTA abhängiger Gene interpretiert werden. Starke Expression eines tTA abhängi-
gen Transgens wurde in der Mauslinie SA87.5 beobachtet. Diese Mauslinie en-
thält drei Kopien des Transgens  im Pik3c3 Genlokus. Die drei Transgenkopien 
wurden durch eine einzige Kopie an derselben Stelle des Pik3c3 Genlokus mittels 
Gentargeting in embryonalen Stammzellen ersetzt. Das Transgen ließ sich jedoch 
bei Anwesendheit des  Neomycinselektionsmarkers nur schwach durch tTA in-
duzieren. Nach Exzision des Selektionsmarkers mittels Cre produzierendem 
rAAV konnte die Induktion des Transgens durch tTA verbessert werden.
   Die Nachteile von fest im Chromosom integrierten tTA regulierten Responder-
genen können durch Einsatz von rAAV als  Vehikel zur Transgenexpression im 
Maushirn überwunden werden. Neben den tTA abhaengigen Respondergenen 
kann auch tTA selbst erfogreich mittels rAAV im Maushirn exprimiert werden. Eine 
gewebespezifische, homogene, schnell anflutende tTA abhängige Expression von 
verschiedenen Genen ist so im Maushirn möglich. Durch Expression mittels  rAAV 
blieben tTA abhaengige Transgene induzierbar, deren Expression bei chromoso-
maler Integartion durch epigenetische Effekte während der Ontogenese zum Er-
liegen kam.
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1: Introduction:
    All biological systems are capable of responding to a vast number of environ-
mental challenges and thus optimize their potential for survival and propagation. 
Depending on the environmental conditions, organisms either activate or inacti-
vate molecular and cellular machinery for short-term or long-term adaptation and 
survival. For example, at the genetic level, gene promoters can become either ac-
tivated or inactivated by modification of gene transcriptional units within seconds 
and gene expression can be modified either transiently or permanently. Molecular 
switches that can turn gene expression “on and off” endow animals  the capability 
to respond and adapt to changes in environmental and cellular conditions. There 
are many naturally occurring inducible gene expression systems, some of which 
have been employed to artificially control gene expression in different animal 
models. Clearly, inducible control of gene expression by artificial means has the 
great advantage as it can provide vital information for correlating gene function(s) 
with phenotypes. Below, I will present a brief overview of different naturally occur-
ing inducible systems, including the tetracycline inducible systems, and how they 
have been modified to create genetic circuits for controlling heterologous gene 
expression in living cells and intact animals. My active studies focused on the Tet-
racycline (Tet) inducible systems for reversible control of gene expression in neu-
rons in vivo.
    
Different inducible systems
Heat shock inducible system 
    The heat shock induced gene regulation system has been exploited in different 
cell lines (Schweinfest et al, 1988) and also in transgenic mice (Kothary et al, 
1989), however its applicability in mammalian systems have been quite limited. 
Heat shock protein genes, such as heat shock protein 70 (hsp70) in D. mela-
nogaster, and hsp68 in C. elegans, contain promoters, which are activated by en-
dogenous heat shock induced transcription factors.
Heavy metal inducible system
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    Heavy metal ions dependent inducible systems, such as one based on metal-
loproteins, are controlled by promoters responsive to heavy metal ions uptake in 
cells, particularly Cd2+ and Zn2+. These systems show high basal promoter activ-
ity, modest level of induction and toxicity associated with administration of heavy 
metal (Filmus et al, 1992). 
Interferon inducible system
    Introduction of the interferon regulated inducible system was greeted with great 
excitement. Genes under the control of interferon-inducible regulatory element, 
such as the promoter of Mx1, could be rapidly activated by injection, double-
stranded RNA, or virus in mice (Arnheiter et al, 1990, Kühn et al, 1995). However, 
limited induction level in tissues and individual mouse, and the fact that treatment 
with either interferon or dsRNA would have profound biological side effects limit 
its general use. 
Steroid hormone inducible systems
    Steroid hormone receptors have also proven as valuable inducible systems. 
Steroid hormones, like glucocorticoid, estrogen, and progesterone, upon binding 
their cognate receptors activate specific genes  containing inducible promoters. 
The natural steroid hormone inducible systems have been harnessed to control 
expression of heterologous genes in mammalian systems but these systems have 
limitations to stringently control gene expression (Friedman et al, 1989, Brasel-
mann et al, 1993, and Wang et al, 1994). Furthermore, hormones  are endoge-
nously produced and regulated in mammals, and the hormone-responsive ele-
ments used to control specific transgene expression would be efficiently regulated 
by endogenous regulatory factors, which respond to the endogenous hormonal 
pathway. That is why hormone receptor mutations are used with high affinity to 
synthetic ligands like Ru486 and tamoxifen are used. As an alternative, the insect 
steroid hormone, ecdysone can be used. It has no cross-reactivity with the mam-
malian systems, and it was applied in mammalian cells  and transgenic mice (Yao 
et al, 1993; No et al, 1996, Albanese et al, 2000, Yu et al, 2000). 
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Lac operon based inducible systems
    There are two well-studied binary regulated gene expression systems, lactose- 
and tetracycline-dependent gene expression systems, described in E. coli. The 
lactose-dependent system consists of two components: a lac repressor (lacR) 
and its  binding DNA sequence-lac operator (lacO). The lac-dependent regulated 
gene expression are under tight control by lactose availability. In E. coli, transcrip-
tion of the survival genes involved in the uptake and metabolism of lactose could 
be efficiently turned on and off. Lac repressor specifically binds to operator (lacO) 
placed in promoter only in the absence of lactose, thus preventing recruitment 
and formation of RNA polymerase transcription initiation complex by steric hin-
derance. Upon treatment with lactose or its derivative, isopropyl β-D-
thiogalactopyranoside (IPTG), the lactose-bound Lac repressor detaches the op-
erator and transcription complex is formed. Transgenic mice have been generated 
using the lacR-dependent gene expression system in mammalian models. For 
example, transgenic mouse systems were established with three tandem lac op-
erators were integrated into the tyrosinease promoter (Caronin et al, 2001). The 
lac repressor repressed mouse tyrosinase promoter activity and upon IPTG 
treatment gene expression was re-activated. One major problem with the lacR 
inducible systems is that IPTG does not readily cross the blood-brain-barrier 
(BBB). For stringent regulation of gene expression in the mammailan brain, it is 
extremely important that the inducers cross the BBB and for this reason most in-
ducible systems discussed have limitations when used in the brain compared to 
peripheral tissues.
Tetracycline operon based inducible systems
    The tetracycline-controlled transactivator (tTA) was  originally designed as a fu-
sion transcriptional factor of Tet repressor (tetR) from the Tn10 tetracycline resis-
tance operon of E. coli and the C-terminal transcriptional activating domain of 
VP16, which is essential for the transcription of immediate early viral genes (Gos-
sen et al, 1992) (Figure 1A). The tTA-responsive promoter (Ptet) is composed of 
tetracycline operator sequences, (tetO), usually heptamerized (tetO)7,  followed 
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by a minimal RNA polymerase II transcription initiation site derived from the hu-
man cytomegalovirus immediate-early (IE) promoter (PhCMV). 
Figure1. The tetracycline-controlled 
transactivators (tTA) and schematic out-
line of tTA regulatory system. A: The 207 
aa tet Repressor (tetR) and the 128 aa 
VP16 domain. In tTA2, 3 F domains was 
fused. B: tTA binds in absence of Dox to te-
tO7, but not in presence of Dox. 
    
    
    They are used to drive the downstream gene of interest. The regulatory TetR 
domain of tTA specifically binds to tetracycline operator sequences (tetO) in the 
absence of tetracycline or one of its  many derivative, such as doxycycline (Dox), 
and thus activates gene transcription (Baron U. et al, 2000). Gene expression can 
be efficiently turned-off by Dox administration (Figure 1B). By symmetrically flank-
ing two CMV minimal promoters with tetO sequences, bi-directional Tet promoters 
have been engineered (Ptetbi) allowing simultaneous  regulation of two different 
transgenes (Baron et al, 1995).
Employment of Tet-systems in transgenic mouse models
    Tetracycline-dependent gene regulatory system is by far the most versatile and 
widely applicable system for gene expression in all cell types in different experi-
mental animal models, such as D. melanogaster (Girard, et al, 1998), plants  (We-
inmann et al, 1994; Zeidler et al, 1996) and mice (Schoenig et al, 2004). As an 
inducible gene expression system, it fulfills the following key requirements for a 
stringent gene regulatory circuit: low basal activity of Tet promoters, high binding 
affinity of Dox to tTA and also tTA to tetOs.  Efficient gene induction is achievable 
with high dynamic range without obvious physiological side-effects on experimen-
tal organisms. The tTA-dependent gene expression system can be efficiently 
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terminal transcriptional activating domain of VP16, known to be essential for the
transcription of the immediate early viral gene (Gossen et al. 1992) (Figure 4A). This
transactivator binds to operator sequence (tetO) of the tet operon in a tetracycline-
dependent manner: When tTA-responsive promoter (Ptet), fused between seven tetO
sequences and a minimal RNA polymerase II promoter sequences derived from the
human cytomegalovirus immediate-early (IE) promoter (PhCMV), is placed in front of
a gene, the tTA mediates on / off situation of gene transcription in presence or
absence of tetracycline or its analogue (Baron U. et al. 2000, Mansuy et al. 2000)
(Figure 4B). The bi-directional promoter, in which the seven tetO sequences (tetO7)
are flanked with two minimal promoters, allows co-regulation of two genes (Baron et
al.1995, Krestel et al. 2001).
Figure 4. The tetracycline-controlled transactivators (tTA) and schematic outline of tTA
regulatory system. (A) The tTA is fusion protein between tet Repressor (tetR), consisting of
207 amino acids, and the 128 – amino acids transactivation domain of VP16. In tTA2, VP16
domain is changed with three minimal activation domains (F domain). (B) Mechanism of the
tTA regulatory system. The tTA binds in absence of the effector molecule doxycycline (Dox)
to an array of seven tet operator sequences (tetO7) placed upstream of a minimal promoter and
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achieved in different tissues and organs of transgenic mice and regulated gene 
expression can be achieved by either oral or intraperitoneal Dox administration. 
Particularly interesting is that the Tet system could be also applied in the nervous 
system of transgenic mice by expressing tTA driven by neuronal specific promot-
ers  (Mayford, 1996). The power of genetic-switch has created much excitement in 
neuroscience research especially to study protein functions in memory and learn-
ing and human-like neurological diseases in experimental animals. The fact that 
the physiological protein function(s) can be switched “on and off” at will in the 
same individual animals provide researchers with a unique opportunity to experi-
mentally test whether diseases might be genetically curable in the future. For in-
stance, transgenic mouse models have been generated to evaluate the func-
tion(s) of key proteins, Prion disease (Prusiner 1997; Tremblay et al, 1998) and 
Huntingtin Disease (Yamamoto et al, 2000) in neuronal plasticity, but also in 
learning and memory (Mayford et al, 1996; Mack et al, 2001). 
    Although tTA has been successfully expressed in the mammalian brain in a 
temporally and spatially restricted manner (Mayford et al, 1996), there is now an 
increased need to further restrict gene expression to specific cell types and 
subregions of the brain so that reversible gene expression in brain circuits can be 
further correlated with phenotypic changes, especially in relation to learning and 
memory. The other problem usually encountered when generating stable trans-
genic mouse lines is that the site of transgene integration in the mouse genome 
has effects on gene expression. We have observed that, compared to other tis-
sues such as liver, tTA-dependent gene expression in the brain is not robust and 
it strongly depends on different Tet-responsive mouse lines, likely due to differ-
ences in site of integration in the genome. If tet-responsive genes are especially 
prone to epigenetic silencing, and especially when integrated in different ar-
rangements in the genomes and as multi-copies, it would be very useful to ge-
netically fingerprint each line in order to account for transgene arrangement as 
one of the variability factors. For these reasons, we undertook a systematic ap-
proach to address these issues. 
    First of all, in vitro and in vivo studies have been performed to improve the 
compatibility of the prokaryotic tTA with the mammalian transcriptional and trans-
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lational systems. The tTA was humanized (itTAnls) by switching codon usage, 
elimination of potential splicing signal, avoidance of CpG sequence, and introduc-
tion of Kozak sequence, and also by increasing mRNA stability etc. (Zolotukhin et 
al, 1996; Cronin et al, 2001; Baron et al, 1997, Regier et al, 1993).  In addition, 
the VP16 moiety in tTA was replaced by three minimal critical activating domains 
(F domain), which was shown to have higher intracellular tolerance and overex-
pression of transcription did not cause squelching effects (Gill and Ptashne 1988; 
Baron et al, 1997, Regier et al, 1993). Optimized tTA are highly proficient in induc-
ing gene expression in cultured cells  (Hasan, 2001; Kim, 2001) and in mice (May-
ford et al, 1996, Malleret et al, 2001, Mansuy et al, 1998, Minichiello et al, 1999, 
Tsien et al, 1996; Chen et al, 1998; Tremblay et al, 1998; Jerecic et al, 1999). We 
used the Thy-1.2 promoter for itTA expression in the mouse brain. The brain spe-
cific promoter fragments of the Thy-1.2 promoter were carefully mapped and in-
vestigated (Spanopoulou et al, 1988 and 1991;). And it is known that the temporal 
regulation of the Thy-1.2 promoter render transgenic mice the ability to express 
the transgene in developmental stage dependent manner (Campsall et al, 2002; 
Caroni, 1996; Feng et al, 2000;). Most importantly, in studies  of many 
Thy-1.2-transgenic mouse models, transgenic mouse lines were established with 
transgenes integrated randomly in the genome and different lines showed brain-
specific gene expression restricted, in some cases, to specific cortical layers and 
cell types (Ingraham et al, 1986; Kolsto, 1986; Kollias, 1987; Spanopoulou, 1988 
and 1991; Caroni, 1996; Feng, 2000; Campsall, 2002;). 
    Second, several Tet-responder transgenic mouse lines as the other part of the 
binary tTA-dependent gene expression system were investigated. In these lines, 
the Tet-responsive DNA constructs are integrated randomly, both in copy-
numbers and in integration loci, into the mouse genome. The Tet-responsive con-
structs contain Ptet-bi to drive the expression of reporter genes bi-directionally un-
der tTA control. To investigate the integration dependence, we determined the 
copy number and genomic locus of the transgene integration in four lines, which 
show stable responder gene expression. The SA87,5 (TgnlacZTETO7GFPGluR-A(SA)) line 
was shown to have the strongest responder gene expression, and it has only 3 
copies of transgene in the Pik3c3 gene locus. Thus, we generated single-copy 
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tet-responsive cassette transgenic mice  (Pik3c3-A1) by ES cell targeting at the 
Pik3c3 locus. To prove the locus-dependent transgene expression, Pik3c3-A1 and 
SA87,5 were bred with KT1 mice to show that tTA dependent transgene expres-
sion is strongly dependent both on integration site and copy-numbers of the tet--
responsive cassettes. 
    Third, recombinant Adeno-Associated Virus (rAAV) carrying tet-responsive 
mini-gene cassettes can escape epigenetic silencing programs and achieve rapid 
and robust tTA-dependent gene expression. The mosaic expression patterns of 
reporter gene observed in ThyF64 (TgThy-1.2(64)-itTAnlsRsp) mice is  supporting the hy-
pothesis  that it is due to the epigenetic silencing effects of integrated tet-
responders. And also previous studies  showed that CMV-derived transgene, 
retro-viral sequences (Flavell et al, 1994; Rossignol and Faugeron, 1994) and 
stably integrated tet-responsive elements containing NEO gene (Shin et al, 1996) 
are strongly influenced by epigenetic silencing programs. To overcome epigenetic 
effects in neurons, we employed rAAV, a human parvovirus with a single strand 
DNA (ssDNA) of about 4,68 kb, to show that non-integrated Tet-responsive DNA 
constructs  can escape epigenetic silencing. rAAV with its dsDNA epigenetic ge-
nome favors  tandem array linear status in the host cells for active long-term tran-
scription, and it rarely integrates into the host genome (Schnepp et al, 2003). 
rAAV containing tet-responder mini-gene (rAAV-6p-minibiCre-Venus) was deliv-
ered into tTA-expressing mouse brains. Robust fluorescent reporter detected in 
selected brain regions of KT1(TgCamKII-tTA) and in Thy1.2 (TgThy-1.2(xx)-itTAnlsRsp) mice 
can be visualized by two-photon microscope to reveal fine neuronal structures  in 
rAAV infected cortical neurons. And the expression of reporter gene can be turned 
off and on by application or removal of Doxycycline in drinking water. More inter-
estingly, we showed that in ThyF64 transgenic mouse brain, the rAAV-tet-
responders mediate tTA-dependent gene expression, which represent tTA ex-
pression patterns of ThyF64. Thus, the combination of tTA-expressing transgenic 
mice and rAAV-tet-responder viruses can mediate rapid and robust gene expres-
sion in tissue- and/or cell-type-specific manner. Apparently, rAAV does not show 
pathological effects in rodents. It has high infection efficiency in dividing and non-
dividing cells cross broad range of hosts and tissues (Samulski et al, 1999; Stil-
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well et al, 2003). The added advantage of rAAV system is convenient and easy to 
use for gene delivery in cells (Clark et al, 1995; Conway et al, 1999; Feudner et 
al, 2001; Gao et al, 1998; Inoue and Russell, 1998; Liu et al, 1999; Matsushita et 
al, 1998; Qiao et al, 2002a, 2002b; Sollerbrant et al, 2001; Xiao et al, 1998; 
Zhang et al, 1999).  Furthermore, we also described that tTA-expressing rAAVs 
using cell-type specific promoters such as human synapsin 1 promoter (Kuegler 
et al, 2001) can achieve transgenic tTA-mice independent conditional gene ex-
pression. The co-infection of rAAV-tTA/rAAV-tet-responder viruses was shown to 
be a powerful tool of delivering a tTA-dependent gene regulation system in mouse 
and in rat brains.
    Finally, rAAV expressing tTA injected into transgenic tet-responder mouse 
brains directly demonstrated epigenetic silencing effects  on integrated tet-
responsive gene cassettes. After detailed analysis  of several tet-responder trans-
genic mouse lines, we introduced high tTA-expressing rAAV into four different 
transgenic tet-responder adult mouse brains. Indeed, integrated tet-responsive 
gene cassettes of most transgenic mouse lines did not show reporter gene ex-
pression in cortical neurons despite high cellular tTA levels. In contrast, transgenic 
tet-responder mice bred with ThyF64 and/or KT1 mice, which have constitutive 
tTA activity through all developmental stages, did show strong reporter gene ex-
pression in the adult mouse brains. In addition, transgenic tet-responder mice: 
TgLuciferaseTETO7Camgroo2 (MTH-CG19) (Hasan et al, 2004), infected with tTA-
expressing rAAV did show robust reporter gene expression in cortical neurons. 
These demonstrated that integrated tet-responsive gene cassettes are actively 
silenced, if there was no active transcription through early developmental stages, 
in cortical neurons of the adult mouse brains. The exception of transgenic MTH-
CG19 responder mice showed the integration locus dependency of epigenetic si-
lencing, which could be employed in generation of transgenic tet-responder 
mouse lines  by targeting the same integration locus, or by using BAC technology 
to keep the genomic environments of the permissive loci.
    Thus, transgenic mouse technology using specific promoters (here mouse 
Thy-1.2 promoter) allows generation of tissue- and cell-type-specific tTA-
expressing mouse lines, which, in combination of rAAV gene delivery systems, 
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achieve rapid and robust tTA-dependent gene expression. Furthermore, tTA-
expressing rAAV and rAAV-tet-responder viruses can mediate strong and cell-
type specific conditional gene expression both in mouse and in rat brains.
Introduction
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2.0 Results.
2.1 Generation of Thy-1.2-(nls)-itTA transgenic mouse lines
    To increase the brain regions accessible for tTA regulated gene expression, we 
generated itTAnls  expressing transgenic mice. The mouse Thy-1.2 promoter (Ca-
roni, 1996) was employed to drive the itTA expression. The itTAnls coding se-
quence was cloned into the Thy-1.2 expression cassette, which carries the en-
dogenous 3’-untranslated regions and its polyadenylation site (Materials and 
Methods) (Figure 2a). After pronucleus injection, 14 founders were obtained. The 
tTA-expression was analyzed in offsprings, which contain the responder gene. 
Reporter β-galactosidase and/or GFP expressing founders were detected and 
analyzed further.
2.2 tTA expression of TgThy-1.2(xx)itTAnls founders were analyzed with indicator 
mice
    tTA-reporter transgenic mouse lines were tTA dependent using different mice. 
Pattern and strength of responder gene expression were analyzed by immunohis-
tochemistry and microscopy. 
    Offspring of different fourteen TgThy-1.2(xx)itTAnls transgenic founders were ana-
lyzed by examining the temporal and spatial expression pattern of lacZ reporter 
line TgGFPTETO7lacZ (G3) (Krestel et al, 2001). To assess the transient activity of 
Thy-1.2 promoter driven itTAnls, the TgGFPTETO7lacZ responder line carrying green 
fluorescent protein (GFP) and β-galactosidase in a bi-directional module was 
crossed to the TgThy-1.2(xx)itTAnls lines as an indicator mouse. In vivo strong GFP 
fluorescence was detected in brains of double transgenic offsprings from founder 
Tg(Thy-1.2-itTAnls)10Rsp, Tg(Thy-1.2-itTAnls)39Rsp, Tg(Thy-1.2-itTAnls)64Rsp. The expression pat-
terns of TgThy-1.2(xx)itTAnls mouse is different from mouse line to mouse line (Tabel 1 
and Figure 2). 
    In lines TgThy-1.2(09, 26, 39, 56, 64)itTAnls , we analyzed tTA expression by using anti-
tTA antibody (tTA/rtTA specific rabbit polyclonal antibodies kindly provided by Dr. 
Beatrix Suess). For these lines we observed a nice immuno-histochemistry and –
fluorescence staining, which could not be obtained for TgCaMKII-tTA mice (data not 
shown).
Results
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Table 1:
Line 
Name
Responder Reporter gene expression in the brain Notes
TgThy-1.2(09) G3
Forebrain specific; cortex layer 5-6; hippocam-
pus; Substantia nigra;  
weak and homogenous 
expression.
TgThy-1.2(10) G3
Forebrain specific; somato-sensory cortex layer 
5-6; hippocampus; Substantia nigra;  
weak and sparse ex-
pression.
TgThy-1.2(15) G3 Very few positive cells in the forebrain. -----
TgThy-1.2(20) G3
Forebrain specific; Cortex; CA1, Lateral amyg-
dala;  
cortical layer 5-6 in so-
matosensory cortex.
TgThy-1.2(26) G3
Forebrain specific; Cortex; Hippocampus; Olfac-
tory bulb; Cerebellum;
few labeling in brain 
stem.
TgThy-1.2(39) G3
Forebrain specific; Cortex layer 2-3; Cortex layer 
5-6; Hippocampal CA1; Substantia nigra;
sparse expression in 
cortical layer 5-6 and 
CA1.
TgThy-1.2(56) G3 cortex, DG, Thylamus, brain stem. sparse labeling
TgThy-1.2(64) G3
Forebrain specific; Cortex layer 2-3; Cortex layer 
5-6; Hippocampal CA1; Substantia nigra; 
sparse expression, 
strong in cortical layer 
5-6 and CA1.
TgThy-1.2(66) G3 Hippocampal CA1 specific expression;
sparse and strong ex-
pression.
    Table 1. Transient activator tTA activity was assessed by crossing TgThy-1.2(xx)-itTAnnls and 
TgGFPTETO7lacZ transgenic lines. Reporter gene expression was observed in various brain regions 
with different intensity and diverse patterns.
   In few cases, we observed that tTA positive cells in double-positive 
TgThy-1.2(64)itTAnls/TgGFPTETO7lacZ mouse brain are negative for indicator gene expres-
sion, which might be due to the epigenetic silencing effects of stably-integrated 
Tet-responder transgene integration locus: TgGFPTETO7lacZ (Figure 10 and Figure 
11). Thus we hypothesized that the efficacy of the Tet-responsive system might 
depend on both the tTA level and the epigenetic state of the responders. Later in 
this  study, we developed viral mediated delivery of Tet-responsive systems to 
prove that stably-integrated Tet-responder transgenes are epigenetically silenced.
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    Figure 2. Strong and sparse transient expression of β-gal  reporter was visualized by enzymatic 
reations. In TgThy-1.2(xx)-itTAnnls transgenic  mouse brains, expression in hippocampus is restricted in 
CA1 and very few neurons in DG, while in the cortex, the expression is restricted in layer 5-6 (a, b, 
d, e and f). TgThy-1.2(15)-itTAnnls /TgGFPTETO7lacZ mice show only very few cells in somatosensory cortex 
(c). TgThy-1.2(66)-itTAnnls /TgGFPTETO7lacZ mice show strong and highly restricted transgene expression 
in CA1 region (g). Ontogenic expression profiles of TgThy-1.2(xx)-itTAnnls were obtained to show activa-
tor activity through early developmental stages (j, k, l and m). TgThy-1.2(09)-itTAnnls /TgLucTETO7Cre/
Rosa26-STOP-lacZ mouse showed homogenous reporter expression in the whole brain, while the 
other three lines showed whole brain expression with only little or no expression in olfactory bulb. 
Scale bar: 0.5 mm.
    To obtain the ontogenic expression profiles of the TgThy-1.2(xx)itTAnls at different 
developmental stages, TgThy-1.2(xx)-itTAnls line were analyzed by TgGFPTETO7lacZ re-
porter lines’ β-galactosidase activity. The β-galactosidase activity was detected 
widely in principal neurons of the forebrain, which show different expression pat-
terns during development (Figure 2). TgThy-1.2(09)-itTAnls showed age-dependent tTA-
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activity in the mouse forebrain (Figure 3), and its ontogenic tTA-profile was ob-
served homogeneously in the whole brain (Figure 2 j). TgThy-1.2(26)-itTAnls also 
showed broad ontogenic tTA-activity in the early developmental stages, but there 
was no activity in the brain stem (Figure 2 k). TgThy-1.2(64)-itTAnls showed overall tTA-
activity in the early developmental periods, while olfactory bulb showed no tTA-
activity (Figure 2 m). In contrast, TgThy-1.2(56)-itTAnls only showed tTA activity in the 
cortex, thalamus and cerebellum (Figure 2 l).
    Figure 3. Developmental stage-dependent expression of TgThy-1.2(09)-itTAnnls transgenic  mouse 
line. TgThy-1.2(15)-itTAnnls /TgGFPTETO7lacZ mice were analyzed at P28, P42 and P60. the expression of 
indicator genes in the brain, both the intensity and the area of expression, is increasing (a-c), in 
hippocampus CA1 region, the expression is sparse and strong (d-f). Scale bars are: 0.5 mm for a-
c; 0.2 mm for d-f;
2.3 Copy-number and integrants pattern of TgThy-1.2(xx)itTAnls founders were 
analyzed by Southern blotting
    From seven out of fourteen independent TgThy-1.2(xx)itTAnls transgenic mouse 
lines, we analyzed the transgene copy-numbers. From different mouse lines 
(TgThy-1.2(09), TgThy-1.2(10), TgThy-1.2(15), TgThy-1.2(26), TgThy-1.2(39), TgThy-1.2(64), 
TgThy-1.2(66)) purified liver genomic DNA was digested and analysed by Southern 
blotting using PCR-amplified DNA probe specific for the endogenous mouse 
Thy-1.2 gene and for the transgene (Figure 4). 
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Table 2:
Line name Transgene Arrangements Copy-number tTA protein level
ThyF09 Tandem 2 low
ThyF10 Tandem 1 low
ThyF15 Tandem 3 low
ThyF26 Tandem 3 high
ThyF39 Complex 3 high
ThyF64 Complex 5 high
ThyF66 Complex 5 low
  
   Table 2. Copy numbers of different TgThy-1.2(xx)-itTAnnls founders was quantitatively analyzed by 
Southern-Blot. 
   These results show that mouse lines TgThy-1.2(09), TgThy-1.2(10), TgThy-1.2(15) and 
TgThy-1.2(26) have simple tandem integrants patterns, while the expressed tTA pro-
tein levels are low in TgThy-1.2(09), TgThy-1.2(10), TgThy-1.2(15) mouse brains, but high in 
TgThy-1.2(26) mouse brain. The other lines, TgThy-1.2(39), TgThy-1.2(64), TgThy-1.2(66) show 
relatively complex transgene arrangements with high tTA levels  in TgThy-1.2(39), 
TgThy-1.2(64) mice, but low in TgThy-1.2(66) mice. It also shows that these 
TgThy-1.2(xx)itTAnls founders carry relatively low copy-numbers of transgenes (Table 
2).
2.4 Transgenes show mosaic and low-level expression in indicator mouse 
lines
    The mosaic expression pattern and the low expression level of reporter gene 
observed in tetracycline-responsive gene expression system had not been fully 
understood. Transgenic TgCamKIIα-tTA and TgCN-itTAnls mouse lines  show undetect-
able tTA expression level in mouse brains analyzed by specific antibodies, which 
are generated against the N-terminal of the tTA molecule (Hasan, et al, 2006).
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      Figure 4. a: Schematic view of Thy-1.2-itTAnls minigene. Wild-type Thy-1.2  gene was di-
gested with BamHI and HindIII, respectively for Southern blot analysis; Minigene Thy1.2-itTA was 
digested with BamHI and HindIII for inner- and outter-probe pattern, respectively; b-c: Southern 
blot analysis of TgThy-1.2(xx)-itTAnls founders. Inner- (BamHI) and Outter-Probe (HindIII) pattern 
were probed in b and c, respectively, with PCR generated probe shown as red bar. B: BamHI; C: 
ClaI; H: HindIII; N: NotI; Nh: NheI; Sa: SalI; Sm: SmaI; 
    It had been disappointing that by immunohistochemistry we could not co-
localize the tTA protein molecules and the reporter fluorescent proteins due to the 
undetectable tTA protein levels in neurons, from which we would have been able 
to understand the mosaic expression patterns. However, the generation of 
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TgThy-1.2(xx)itTAnls transgenic mice provide some insight into mosaic expression pat-
terns seen in tTA system. The TgThy-1.2(xx)itTAnls transgenic mice were demonstrated 
to have faithfully detectable itTAnls expression in neurons.  
    
    Figure 5: TgThy-1.2(64)-itTAnnls /TgGFPTETO7lacZ mouse brain was analyzed by immunohistochem-
istry using FITC-anti-β-galactosidase (a); Cy3-anti-tTA (b). Hippocampus CA1 neurons were 
labeled (a and b) and colocalized (c); Cortical neurons were labeled (d and e) and colocalized (f); 
to show the overlapping expression of β-galactosidase indicator and tTA protein in cortex and in 
hippocampus. Arrowheads show some of the cells with relatively low β-galactosidase expression 
despite high levels of tTA.
    In Tg(Thy-1.2-itTAnls)64Rsp and TgGFPTETO7lacZ double positive transgenic mice, we de-
tected the co-localization of tTA and GFP by immunohistochemistry using poly-
clonal rabbit anti-tTA and mono-clonal mouse anti-GFP antibodies, respectively. In 
most tTA expressing cells, reporter gene expression could be detected. However 
in few exceptions in cortex and hippocampal neuron populations, despite the 
presence of immuno-detectable tTA, the TgGFPTETO7lacZ Tet-responder integrant 
could not be efficiently activated. This might be the reason of mosaic expression 
patterns (Figure 5). These results show that the presence of high level of tTA is 
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not always sufficient for transgene reporter activation, suggesting that mosaic ex-
pression in the Tet system is caused by variable accessibility of the Tet-
responsive transgene integrant in nerve cells.
2.4.1 Transgene Copy-Number and Pattern analysis by Southern-Blotting
     We selected three different responder lines with stable by mosaic expression 
of the transgenic line: TglacZTETO7gfpGluR-A, TglacZTETO7gfpGluR-A(SA) and TgGFPTETO7lacZ. 
We find that TgGFPTETO7lacZ trangenic locus is low in copy number (3-4 copies) and 
of a simple integration pattern (Figure 6A).  
    The Southern blot analysis showed that TglacZTETO7gfpGluR-A locus also has the 
feature of low-copy number (8-10 copies) and again a simple transgene integra-
tion pattern (Figure 6B).    
     The Southern blot analysis showed that the GFPGluR-A(SA) transgene integra-
tion locus has low-copy number (2-3 copies) and the multi copies were arranged 
simply in tandem repeats pattern (Figure 6C).
2.4.2 Copy-Number analysis by Quantitative RT-PCR and Sequencing
      Real-time (RT) PCR could quantitate the relative amount of a given template. 
We used Real-Time PCR to confirm the copy-number determination from South-
ern blots. For mouse lines: TgGFPTETO7lacZ; TglacZTETO7gfpGluR-A(SA); TglacZTETO7gfpGluR-A, 
we designed specific primers, and FITC- or Fam-labeled probes. Wildtype allele 
Gria1 was used as  internal control. The results  showed that TgGFPTETO7lacZ has 4 
copies; TglacZTETO7gfpGluR-A(SA) has 2 copies and TglacZTETO7gfpGluR-A has 10 copies of 
transgene (Figure 7a). Next we used the Chromatograph file in sequencing reac-
tions, as an alternative method, to determine the copy number of TglacZTETO7gfpGluR-
A and TglacZTETO7gfpGluR-A(SA) transgenic mice. Transgenic constructs  of 
TglacZTETO7gfpGluR-A and TglacZTETO7gfpGluR-A(SA) transgenic mice are originally derived 
from rat cDNA library (Mack et al, 2001). Thus the Single Nucleotide Polymor-
phisms (SNPs) in rat and mouse GluR-A coding sequences were used to calcu-
late the copy-number (Figure 7b).
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Figure 6. Schematic 
views of the mini-
gene constructs 
from G3,  A1.1 and 
SA87.5 transgenic 
mouse lines and 
S o u t h e r n b l o t 
analysis. Southern 
blot analysis was 
performed using 
PCR amplied probes 
(red bar). A: Inte-
grant in G3 mice 
were analyzed by 
EcoRV and StuI, 
which show tandem 
arrangement of 3-4 
copies of transgene;
 
B: TglacZTETO7GFPGluR-
A mouse was ana-
lyzed by BglII and 
EcoRV to show tan-
dem array of 8-10 
copies of transgene; 
C: Four restriction 
enzymes : Bg l I , 
BglII, EcoRV and 
StuI, were used to 
a n a l y z e 
Tg lacZTETO7GFPGluR-
A(SA) mouse DNA. 
Pattern shows that 
2-3 copies of trans-
gene were arranged 
in tandem in the 
integration locus; B: 
BglI; Bl: BglII; EV: 
EcoRV; St: StuI;
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    These results  showed that the copy number of the transgenic mouse lines de-
tected by RT-PCR and by sequencing reactions, fits well in certain range com-
pared to the Sounther-Blots analysis. Therefore, due to fast, easy and cheap per-
formance, sequencing reactions mentioned here should be considered signifi-
cantly as alternative means to detect transgene copy-numbers. However, the 
sensitivity of sequencing chromatograph shows major limitations in analyzing high 
copy-numbered transgenic animals.
             
    Figure 7: Transgene copy numbers were analyzed by Real-Time PCR and quantitative 
chromatography sequencing. a: Specific Real-Time PCR analysis show that 
TglacZTETO7GFPGluR-A(SA87.5), TglacZTETO7GFPGluR-A and TgGFPTETO7LacZ lines has 2, 10 and 4 copies of 
transgene constructs, respectively. b: The chromatograph shows that duplex of traces were com-
pared and analyzed using equation shown beneath it, from which the copy numbers were calcu-
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lated. Results are TglacZTETO7GFPGluR-A(SA87.5) has about 2 copies and TglacZTETO7GFPGluR-A has 7 cop-
ies.
2.4.3 Transgene Integration Sites detected by PCR-Mediated Genome Walk-
ing.
     For the detection of precise transgene integration site in the genome, the tar-
geted ROSA26 (ROSA-lacZ) line mouse liver DNA was  used as  a positive control 
for establishing the methods. The ROSA26LacZ heterozygous mice contain one 
allele of reporter gene and one wildtype ROSA26 allele. ROSA26lacZ mice livers 
were isolated and purified as described (Materials  and Methods). Genomic DNA 
was digested using specific blunt-end restriction enzymes: EcoRV; StuI; MscI etc. 
Next the GenomeWalker libraries were constructed. The GenomeWalking PCRs 
were set up according to manufactor’s instructions with slight modification (Mate-
rials and Methods) using ROSA26LacZ-Transgene-Locus-specific primers: ro-
sa15 and rosa16. The amplicons of PCR products were analyzed on 1.0% EtBr/
Gel. Many test runs were performed to establish the proper thermo-cycles for 
Touch-Down PCR programs. Amplified fragments were gel-purified and subjected 
to sequencing. To illustrate the genomic loci sequences, which could be used to 
identify the genomic loci of transgene integration by blasting the public genome 
Databases: NCBI, UCSC and Celera System. After analyzing the sequencing 
trace data using SeqMan (LaserGene V6, USA) program, the ROSA26 locus 
could be identically matched in all public genome Databases mentioned above.
    Transgenic TgGFPTETO7lacZ, TglacZTETO7gfpGluR-A and TglacZTETO7gfpGluR-A(SA) positive 
mice were then analyzed similarly by Genome Walking using beta-globin polyA 
specific primers (G03/G04 and G08/G09) and human growth hormone polyA spe-
cific primers (H03/H04). The precise location of the integration site was mapped 
in Celera (ABI, USA) and public genomic Database.
2.4.4 Transgene Integration Sites were confirmed
    Several well studied transgenic mice models were analyzed by GenomeWalk-
ing, and the according transgene integration sites were matched to the public ge-
nome Databases. To confirm the results, specific primers flanking the genomic 
sequences of the integration site were designed. The FP- and RP-primers com-
Results
20
bined with transgene-specific primers used in detecting the integration sequences 
were subjected in PCR reactions. Amplification products were purified and se-
quenced, and analyzed using SeqMan (LaserGene V6, USA) program with 
matching Reference Sequences.  All detected transgene integration sites could 
be confirmed by PCR and sequencing, and the predicted cutting pattern of 
Southern blot data were also matched to band-pattern in most of negatives shown 
in Southern blot analysis.
    Figure 8. Genome overview of the integration sites for transgenes: TglacZTETO7GFPGluR-A 
(A1), TgGFPTETO7LacZ (G3) and TglacZTETO7GFPGluR-A(SA87.5) (SA87.5), TglacZTETO7GFPGluR-A(SA4.2) (SA4.2) 
transgene integration sites with other highlighted gene loci. Important genes for the lab are 
given as reference: NR1: NMDA Receptor subunit 1; NR2A, NR2B, NR2C and NR2D: NMDA Re-
ceptor subunit 2 A, B, C and D; GluR-A, -B, -C and -D: glutamate AMPA Receptor A, B, C and D; 
ROSA26: Gt(ROSA)26Sor locus;
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 Figure 9: Genome location of TglacZTETO7GFPGluR-A , TgGFPTETO7LacZ and TglacZTETO7GFPGluR-A(SA87.5) 
transgene integration loci (Applied Biosystem Celera Discovery System). A: 
TglacZTETO7GFPGluR-A transgene was integrated into Chromosome 16 at 37,106,406 bp position, near 
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gene mCG1038012 (Immunoglobulin superfamily, member 11) and mCG1038012 (Pseudo gene 
predicted by computer software, no transcripts or protein were detected so far); B: TgGFPTETO7LacZ 
transgene was incorporated into Chromosome 17 at  43,287,531 bp, near gene mCG13942 (CD2 
associated protein) and mCG13949 (Tumor necrosis factor superfamily, member 21); C: 
TglacZTETO7GFPGluR-A(SA87.5) transgene was inserted into gene mCG124384 (RIKEN cDNA 
5330434F23 gene. PI3 kinase family member), on Chromosome 18 at 27,772,916 bp position;
   The results show that TgGFPTETO7lacZ transgene locus is at position: 43,287,531 
bp on Chromosome 17 (Figure 8 and Figure 9B); TglacZTETO7gfpGluR-A transgene lo-
cus was found on Chromosome 16 at 37,106,406 bp (Figure 8 and Figure 9A); 
TglacZTETO7gfpGluR-A(SA) transgene locus position is on Chromosome 18 at 
27,772,916 bp (Figure 8 and Figure 9C). The exact positions of the integration 
loci are given according to the scaling in Applied Biosystem Celera Discovery 
System (year 2003-2005).
2.4.5 Homozygosity of the Transgenic Mouse Lines.
    To discover the potential importance of the integrated gene loci and to reduce 
the workload of keeping the transgenic mouse lines, transgene homozygosity 
identification was carried out using integration sites flanking FP- and RP-primers. 
For TgGFPTETO7lacZ (G3) line, specially designed transgene integration site specific 
primers were used to genotype the offsprings (Figure 10A and 10B). Three homo-
zygous out of 18 offsprings were confirmed to be TgGFPTETO7lacZ (G3) homozygous 
(Figure 10C and 10D). However, the homozygous TgGFPTETO7lacZ animals  die be-
tween P15 and P42. The reason for death is  unclear, since the transgene cas-
settes integrated into a 50 kb long stretch non-coding genomic DNA. Whether the 
expression of the neighbouring loci: are affected remains to be worked out.
    For TglacZTETO7gfpGluR-A line, the transgene integrated into a long non-coding ge-
nome region: Chromosome 16, position 37 mega bp. Though the integration hap-
pened in non-coding region, we could not manage to get any homozygous off-
springs from TglacZTETO7gfpGluR-A line. For line TglacZTETO7gfpGluR-A(SA), PCR reactions 
with junction primers recognizing both the transgene- and wildtype allele genomic 
sequence, revealed no rearrangement in the wildtype allele, although about 100-
200 nucleotide inverted short copy from the genomic sequence at the junction of 
transgene-genome boundaries could be detected. 
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  Figure 10. Spe-
c i fi c a l l y  d e-
signed primers 
could efficiently 
detect homozy-
gous TgGFPTE-
TO7LacZ t r ans-
genic mice. A: 
Schematic trans-
gene allele shows 
integration junc-
tion and the flank-
i n g p r i m e r s : 
primer 01: ge-
nome specific 
primer; primer 02: 
transgene specific 
primer. B: Sche-
matic wildtype 
allele shows two 
genome specific primers flanked integration site. C: Genotyping PCRs using normal transgene 
specific primers detect either transgenic (positive) or wildtype (negative) indivaduals. D: Complex 
homozygousity-genotyping PCRs using primer 01, 02 & 03 detect wildtype, hetrozygous and ho-
mozygous TgGFPTETO7LacZ individuals.
2.5 Deliver new Tet-responsive cassette into transgene integration site of 
TglacZTETO7gfpGluR-A(SA)
    After the TgGFPTETO7lacZ, TglacZTETO7gfpGluR-A and TglacZTETO7gfpGluR-A(SA) transgene 
integration loci were detected by GenomeWalking and confirmed, we decided to 
target the locus with new but a sequence comparable Tet-responder cassette to 
analyze if retargeting with a different responder cassette gives comparable re-
sults. Among the analyzed transgenic mouse lines, TglacZTETO7gfpGluR-A(SA) trans-
genic mice showed the highest level of responder gene expression induced by 
TgCamKIIα-tTA mice, and low-copy number of transgenes were integrated in simple 
tandem repeats pattern. Therefore, the TglacZTETO7gfpGluR-A(SA) locus might be a 
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good candidate for generating transgenic mice by locus specific single-copy 
Knock-In experiments.
2.5.1 TglacZTETO7gfpGluR-A(SA)-Transgene-Integration-Locus is gene: Pik3c3  
    As mentioned above, TglacZTETO7gfpGluR-A(SA) transgene was integrated into 
Chromosome 18 at position : 27,772,196. It is inserted in the 11th intron of gene 
Pik3c3, which belongs  to PI3 kinase family, subfamily 9. The function of the pro-
tein is  not defined up to now. However, till now we could not obtain any 
TglacZTETO7gfpGluR-A(SA) homozygous transgenic mice, which might indicate the im-
portant function of Pik3c3 during the early stage of development. Though the pro-
tein function was not well investigated, the mRNA expression was investigated in 
details  in different tissues  and through the developmental stages (Figure 11; GNF 
database), which indicates  that the Pik3c3 gene locus is active (see below), 
therefore should be accessible in most adult mice brain regions.
 
    
    Figure 11: Pik3c3 gene 
expression atlas (adapted 
from GNF Mouse Gene At-
las library). Relative expres-
sion intensity of mRNA de-
tected in various tissue ex-
tracts. Here shows that gene 
Pik3c3 is actively expressed 
in all  samples, with brain 
subregions and B-cells out-
standing.
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2.5.2 Expression Analysis of Endogenous Pik3c3 gene by in situ Hybridiza-
tion
    The GNF data base has shown that the mRNA of Pik3c3 is expressed in vari-
ous regions of adult mouse brain. However, the data base does not indicates the 
anatomical details, which might be important information for brain-specific trans-
genic mouse model generation. Thus, in situ hybridization was carried out to illus-
trate the endogenous expression profile of Pik3c3 mRNA. Oligonucleotide probes 
were designed specifically binding to exon 11, exon 14 and the junction of exon 
14 and 15, respectively. And NMDA Receptor 1 specific Oligonucleotide probe 
was used as  positive control for the hybridization procedure (Figure 12A). In situ 
hybridization using exon 14 specific probes  showed that the mRNA of gene 
Pik3c3 is expressed in olfactory bulb and most brain regions, including hippo-
campus, cortex and cerebellum (Figure 12B). These results  demonstrate that the 
Pik3c3 locus is  active in various tissues, therefore it might be accessible for tTA 
trans-activation in the adult mouse brain. The results also fit to the the GNF data 
showing the mRNA expressed in most stages of mouse development and regions 
of the mouse brain. 
    
Figure 12: Horizontal in situ hy-
bridization was performed to show 
the anatomical expression atlas of 
Pik3c3 gene. A: Positive control was 
performed in parallel by NMDA Re-
ceptor 1 oligonucleotide probe. B: 
Oligonucleotide probe against exon 
14 was shown here, which illustrates 
the expression of Pik3c3 in hippo-
campus, cerebellum and cortex.
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2.6  Targeting  constructs  were  made  for  Pik3c3  locus
    Next we carried out experiments to target the locus with new transgene con-
structs by homologous recombination in ES cells. First, specific primers flanking 
the locus  of 1.0 kb genomic sequence were designed and PCRs were performed 
to amplify the genomic sequence from both C57Bl6 wildtype mice and SV129/K1 
ES cell. The PCR products  were subjected to sequencing reactions to determine 
the Single-Nucleotide-Polymorphism (SNP). The trace data shows that there is no 
SNPs detected in 1.0 kb of genomic sequence, neither among 3 individual 
C57Bl6 wildtype mice, nor between C57Bl6 and SV129/K1 ES cell genome. So 
the Pik3c3 locus will be a perfect locus for ES targeting in SV129/K1 ES cell line 
using PCR amplified homologous arms.
    Second, the BAC (bacterial artificial chromosome) clone: RP24-185E11, con-
taining the Pik3c3 locus genomic sequence was ordered from BACPAC company 
(USA). By PCR reactions and sequencing, using Pik3c3-locus-specific genomic 
primers, the identity of the BAC was verified .
    Third, the homologous arms of 6.7kb-longarm and 2.2kb-shortarm used for tar-
geting vector were obtained from PCR reactions  using the BAC as template se-
quence. A multiple cloning site was introduced into the vector containing two ho-
mologous arms. Before further processes, the homologous arms cloned into 
pLongShortArmsTK were sequenced and analyzed by specific restriction en-
zymes. Sequencing reactions  were performed and sequencing results showed 
that there are no mutations from either the PCR reactions, or cloning procedures.
    Fourth, a tet-reporter-transgene-cassette was cloned into the targeting vector 
between the short- and long-arm. The tet-reporter transgene cassette was com-
parable: pnlacZ-tetO7-GFPGluR-A(flip) to the transgenic insertion in 
TglacZTETO7gfpGluR-A(SA) and had only 3 nucleotides differences. Both cassettes ex-
press reporter genes under the control of bi-directional CMV minimal promoters. 
The reporter β-Galactosidase, and GFPGluR-A as wild-type protein (new cassette) 
or as C-terminal mutant (TglacZTETO7gfpGluR-A(SA) line cassette). 
       After the modification of the backbone sequence, plasmid pnlacZ-GFPGluR-
A(i) was cut by Hind III  and Ase I, which released the nlacZ-GFPGluR-A(i) frag-
ment. The nlacZ-GFPGluR-A(i) DNA fragment was cloned between PacI and AscI 
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sites of the modified pBackbone (Figure 13a). After that, the nlacZ-GFPGluR-A(i) 
fragment was released by PacI and AscI, and cloned into linearized, PacI, AscI 
digested pLongShortArmsTK, which carries the homologous arms for targeting to 
generated the targeting vector (Pik3c3-A1.1) (Figure 13b).
    Figure 13: Schematic views are shown to illustrate the high homology of two constructs: 
Minigene pLacZ-tetO7-GFPGluR-A(S843A & S831A) of transgenic SA87.5 mice was shown in (a). 
Pik3c3-A1 targeting construct: pLacZ-tetO7-GFPGluR-A with neo-selcetion marker (b)   was deliv-
ered into Pik3c3 locus. The new construct: pLacZ-tetO7-GFPGluR-A has only 3 nucleatides differ-
ence in the C-terminal of GluR-A coding region after neo removal (c).
2.7 Embryonic Stem Cell Targeting
2.7.1 PCR Selection of neo-Resistant ES-Colonies
    The targeting construct: Pik3c3-A1.1 was linearized by NotI and electroporated 
into ES cells (Materials and Methods). After 8 days of neomycin selection, the 
exon10 exon11exon09
lacZgfpGluR-A
tetO7
exon10 exon11exon09
lacZgfpGluR-A
tetO7 pgk neo
exon10 exon11exon09
chr.18: 27,772,916 bp
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831845
tetO7
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......copy 3
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c
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neo-resistant colonies  were isolated and expended. Small amount of DNA was 
extracted. Before PCR analysis, the quality of the genomic DNA was controled on 
1.0% agarose gel (Figure 14). According to the targeting strategy, PCR primers 
were designed flanking the short-arm of the targeted locus (Primer FP-SA-400 
and RP-SA-400). Long-template PCR were performed using these primers to 
identify the targeted ES clones by showing the expected PCR amplicons with 2.6 
kb in size (Figure 14). From 250 ES colonies analyzed, twelve PCR-positive colo-
nies: clone C-G1, clone D-D3 for example were further expended and DNA was 
extracted and purified for Southern blot analysis (Figure 15). 
    Figure 14: Genomic DNA extracted from different ES clones was checked on gel and 
PCR identified correctly targeted clones.
2.7.2 Southern-Blotting Analysis of PCR-Positive Colonies
    Since PCR analysis of the ES colonies could only give one hint that the Pik3c3 
locus was correctly targeted. Southern blot analysis was carried out on the ge-
nomic DNA of PCR-positive colonies to confirm there is only one correctly tar-
geted transgene copy. The genomic DNAs were digested using BglII and AflII re-
striction enzymes (Figure 15a). Southern blot probe was located between primer 
pair neo04 and neo05 on the junction of the loxP-pgkneo-loxP and 2.0kb short 
arm (Figure 15a). The specific size and pattern of the Southern blot showed the 
correctly targeted ES colonies, which might be ready for generation of mice by 
Blastocyte ES cell injection (Figure 15b).  
1.0% Gel; 45 min; 125 Vs;
Genomic DNA
quality control
PCR results
20.- kb
2.6 kb
Plate D-D3Plate C-G1
ES colony ES colony
Bad DNA quality, but 
PCR is present!
ES colony
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    Figure 15: Targeting constructs were designed with Long- and Short-homologous arms, 
and Southern-Blot analysis was performed to verify the PCR selected ES clones. Schematic 
view of the targeted allele was shown in (a) with Afl II and Bgl  II (both are external probe-pattern) 
located beneath showing the Southern blots band size. Southern blot negative was developed 
after 3 weeks exposure, showing specific  bands at 6.9 kb and 5.3 kb for Afl II and Bgl II, respec-
tively (b).
 2.7.3 Cloning of AAV-itTAnls virus for fast application of itTAnls in vitro
    Before the blastocyst injection of correctly targeted ES colonies, it is important 
to know if the positive ES clones could function in vitro as tTA reporter transgene, 
which had been targeted into Pik3c3 locus of the positive ES colony. For this pur-
pose, we developed recombinant Adeno Associated Viruses (rAAV), which were 
constructed to express improved tTA (itTAnls) described previously. The itTAnls 
was cloned into pAAV-MCS (Figure 19) to get rAAV-cmv-itTAnls. The rAAV-cmv-
itTAnls virus was examined and titrated in HEK293FT cell culture before applica-
tions. rAAV-cmv-itTAnls virus (5 µl) was added into the ES cell culture with gentle 
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shaking. After 3 days incubation, the ES cell culture was washed twice with 1x 
PBS buffer and fixed by 4% PFA solution for 10 min at RT. After washing with 1x 
PBS, enzymatic staining was performed using X-gal solution at RT overnight 
(Figure 20). It showed that the targeted ES colony could be induced by tTA in vi-
tro. This  demonstrated the tetracycline-responsive gene construct was functional. 
Then, the targeted ES colony was prepared as described in Materials and Meth-
ods for blastocytes injection to generate mouse line, named Pik3c3-A1. Fourty 
injections were performed to generate Pik3c3-A1 mice. Four high chimeric mice 
were born and the targeted locus was transmitted in 2 founders. The mice were 
identified by coat color and genotyping PCR using transgene- and integration-
locus-specific primers, respectively.
2.8 Analysis of Pik3c3-A1 mice with transgenic tTA mouse lines
    Next we asked whether we could obtain the same expression pattern and in-
tensity of the targeted mice using GFPGluR-A when compared to the transgenic 
line TglacZTETO7gfpGluR-A(SA). For this, Pik3c3-A1 mice were crossed to TgCamKIIα-tTA 
and/or TgThy-1.2(xx)itTAnls founders and compared with TglacZTETO7gfpGluR-A(SA)/TgCamKIIα-
tTA (or TgThy-1.2(xx)itTAnls) double positive mice.
 
Figure 16: rAAV-CMV-itTAnls 
was cloned. nlstTA was liber-
ated cloned into pAAV-MCS 
vector to generate recombi-
nant AAV ‘gutless’ constructs 
for virus production.
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2.8.1 Analysis of Pik3c3-A1 mice bred with TgCamKIIα-tTA (8.5kbCaMKII-tTA) 
transgenic mice
    After one generation of back-crossing to C57Bl6, the positive Pik3c3-A1 mice 
were bred with TgCamKIIα-tTA. Double positive mice were sacrificed and brains were 
analyzed by immunohistochemistry. The brain slices were stained against re-
porter gene products by polyclonal rabbit anti β-galactosidase using DAB staining 
methods. It was, however, disappointing that only small fraction of striatum cells 
were positive (Figure 17 A 1-5), which indicated the low expression of transgene 
under TgCamKIIα-tTA induction. There were no signals visible in other brain regions. 
The results showed that Pik3c3-A1/TgCamKIIα-tTA carrying neo-selection marker 
gene did not inherit the expression pattern and intensity of TglacZTETO7gfpGluR-A(SA)/
TgCamKIIα-tTA mice. 
   Thus, the presence of the Neo selection marker might inhibit the tTA-dependent 
gene regulation. We supposed that the neo selection marker hinders the expres-
sion of nearby promoters due to epigenetic silencing of the Ptet-bi transgene cas-
settes. Removal of the neo-selection marker is  therefore necessary for a site by 
site comparison.
2.8.2 Reporter gene expression pattern of Pik3c3-A1 mice showed no sig-
nificant difference when bred with TgThy-1.2(xx)itTAnls transgenic mice com-
pared with TgCamKIIα-tTA mice
    Furthermore, we would like to know whether extremely high level of nuclear lo-
calized tTA would rescue the expression levels and patterns in Pik3c3-A1 mice. 
Pik3c3-A1 mice were bred with Tg(Thy-1.2-itTAnls)64Rsp, one of the highest tTA-
expressing founders. Pik3c3-A1/Tg(Thy-1.2-itTAnls)64Rsp double-positive mouse brains 
were analyzed. The results were comparable to Pik3c3-A1/TgCamKIIα-tTA reporter 
gene expression, that is, no enzymatic β-gal activity was observed in cortical neu-
rons (Figure 17 B 1-5). Therefore, the results  further support the hypothesis of 
epigentic silencing of Pik3c3-A1-neo transgene cassette due to the presence of 
the neo-selection marker gene. Despite of high cellular tTA levels in cortical neu-
rons, in the presence of neo gene, Pik3c3-A1 did not show detectable reporter 
gene expression in cortical- and hippocampal neurons.
Results
32
    Figure 17. Immunohistochemstry and enzymatic activity analysis of TgCamKII-tTA/SA87.5, 
TgCamKII-tTA/Pik3c3-A1, ThyF64/G3 and ThyF64/Pik3c3-A1 double positive mouse brains. 
TgCamKII-tTA/SA87.5 mice were analyzed as positive control for nucleus localized β-gal using poly-
clonal β-gal antibody immunostainings, many β-gal positive cells were detected in cortex, CA1 
and striatum (A 1-4); Sparse β-gal  positive neurons were observed only in srtiatum of double 
positive TgCamKII-tTA/Pik3c3-A1 mouse brain (B 1-4) by immunochemical stainings. ThyF64/G3 
double positive mice were analyzed as positive control for β-gal enzymatic activity stainings, many 
β-gal positive neurons were detected in cortex, CA1(C 1-4). No β-gal  enzymatic activity was ob-
served for overnight stainings (D 1-4) in double positive ThyF64/Pik3c3-A1 mouse brain.
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2.8.3 Removal of neomycin selection marker gene from Pik3c3-A1 using 
rAAV-6p-minibiCre-Venus reprogramed epigenetic silencing in Pik3c3 locus 
    Next we examined if removal of neo-selection marker gene would reprogram 
the epigenetic silencing effects in Pik3c3 locus and therefore show enhanced re-
porter gene expression. To remove the neo marker, we applied rAAV-6p-
minibiCre-Venus virus injection into double positive Pik3c3-A1 / Tg(Thy-1.2-itTAnls)64Rsp 
mouse brains. tTA expressed from Thy-1.2-itTAnls minigenes in double positive 
Tg(Thy-1.2-itTAnls)64Rsp/ ROSA26-nlacZ (lacZ indicator mouse) was shown to be able 
to induce Cre recombinase mediated gene recombination in vivo within 10 days 
(data not shown). Virus rAAV-6p-minibiCre-Venus infected Pik3c3-A1 / 
Tg(Thy-1.2-itTAnls)64Rsp mice were analyzed 14 days post-infection. Improvement of 
gene expression was shown by reporter β-gal activity, which was detected spe-
cifically in infected cortical neurons (Figure 18 a-c), but not on the contralateral 
side of the brain (Figure 18 d-f). 
 
    Figure 18. Pik3c3-A1/ThyF64 double positive mice showed improvement of reporter gene 
expression after neo selection marker gene removal. a-c: In rAAV-6p-minibiCre-Venus in-
fected cortical neurons of double positive Pik3c3-A1/ThyF64 mouse brain, reporter β-
galactosidase expression from targeted nlacZ-GFPGluR-A tet-responsive construct was detected; 
but absent in the uninfected contralateral side (d-f).
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    More interestingly, due to the fact that ThyF64 express tTA specifically in layer 
5-6 cortical neurons in somotasensory cortex, the β-gal reporter was detected 
only in layer 5-6 cortical neurons in somotasensory cortex. Thus, by delivering 
rAAV-6p-minibiCre-Venus virus into double positive Pik3c3-A1/ThyF64 transgenic 
mouse brains, we showed Pik3c3-A1 is inducible after neo marker removal.
2.9 Working with recombinant Adeno associated viruses (rAAV)
    The mosaic expression pattern observed in all tTA-controlled transgenes, re-
gardless of CaMKIIα or Thy-1.2 promoter, low or high tTA levels  in the brain, is 
supporting the hypothesis  of epigenetic silencing of stably-integrated tetracycline-
responsive transgenes. The silencing might happen to the integrated transgenes 
by chromatin reorganizations or by other mechanisms. To answer this  question, 
we used rAAV as  Tet-responsive gene delivery system. rAAV had been shown as 
powerful gene delivering system both in primates  and rodents. rAAVs infect a 
broad range of host cells  with high rates and also mediate high levels  and long-
term expression of virus delivered genes. rAAV has been shown to have no neu-
rovirulence observed relative to high-dose (>107 particles) and long-term (2.5-8 
months) infection of rAAV. And most importantly, there have been shown as epi-
somal DNA virus, which forms multicopy concatemers, and rarely integrates into 
the host genome incurring cellular toxicity. Thus, if episomal tet-responder can be 
activated by tTA, but not the transgenic tet-responders, this could be the ultimate 
proof that tet-responder transgenes are silenced in absence of transcription activ-
ity.
2.9.1 Construction of recombinant Adeno associated viruses
    Several tTA and/or rtTAnls  expressing rAAV viruses were cloned and tested in 
dissociated neuronal cultures. First, pAAV-CMV-itTAnls and pAAV-CMV-nlsrtTAnls 
are made for generation of rAAVs, which express itTAnls or rtTAnls driven by 
CMV-promoter (Figure 19 a). In vitro culture tests showed us that the CMV-
promoter could lead relative strong expression of tTA/rtTAnls  in cultured non-
neuronal cells within 3-10 days post-infection. We further cloned pAAV-hSyn-
itTAnls and pAAV-hSyn-nlsrtTAnls plasmids (Figure 19 b) for production of rAAV 
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expressing tTA driven by human synapsin 1 promoter, which was shown to have 
strong promoter activity specifically in neurons (Kuegler, 2003). Furthermore, we 
also developed mini-tet-responder rAAVs. Ptet-bi CMV promoters  were used to co-
express Venus and Cre-recombinase in rAAV (rAAV-6p-minibiCre-Venus) (Figure 
19 c). The rAAV-hSyn-itTAnls, rAAV-hSyn-nlsrtTAnls and rAAV-6p-minibiCre-
Venus were produced, purified and tested both in vitro and in vivo. The results 
described below will show that rAAV-hSyn-itTAnls, rAAV-hSyn-nlsrtTAnls  and 
rAAV-6p-minibiCre-Venus viruses are very efficient and powerful tools in deliver-
ing Tet-responsive reporter gene expression systems in the CNS of rodents 
brains, independent of any transgenic mouse models.
     Figure 19: Schematic view  of three rAAV constructs. a: CMV promoter was used to drive 
itTAnls or rtTAnls expression in rAAV-CMV-itTAnls/rtTAnls viruses. b: Human Synapsin1 promoter 
drives itTAnls or rtTAnls expression in rAAV-hSyn-itTAnls/rtTAnls viruses. c: Ptetbi CMV minimal 
promoters were used to simultaneously expression Venus and Cre-recombinase in rAAV-6p-
minibiCre-Venus virus.
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2.9.2 Cross-dressing and purification of rAAV
    There are many advantages of using recombinant AAV as gene delivery sys-
tem in rodent brain, one of them is  the purity of the rAAV will not cause any im-
mune response in long term application of the virus (Kuegler, 2003). The most fa-
vored rAAV purification method is Heparin-Affinity binding column (Amersham, 
USA), which has extremely high binding efficiency to serial type 2 rAAV virus cap-
sid. rAAV serial type 2 surface antigen was known to mediate moderate infection 
in brain compared to other serial types, such as serial type 1, 3 and/or 5. To ar-
chive high-titer stock preparation and to reach the maximum infection efficacy in 
brain tissue, two Helper plasmids, serial type 1 and 2, were co-transfected with 
rAAV genome vector in HEK293 cells (Invitrogene, USA). Three different mixing 
ratios of serial type 1 and 2 Helper plasmids were prepared and used to produce 
rAAV-CMV-Venus, which was shown to have strong expression of fluorescent Ve-
nus protein in HEK293 cells. After harvesting and treatment of the crude virus 
stock as described in Materials and Methods, they were loaded onto pre-casted 
Amersham Heparin-5ml-column. The purified rAAV-CMV-Venus cross-dressed 
with three different Dp1:Dp2 ratios were titrated on monolayer HEK293 cells. The 
Heparin-5ml-column binding efficiency of cross-dresssed rAAV viruses were cal-
culated and compared with previous publications, which showed the same results 
of about 30 times virus  enrichment (10 ml concentrated into 0.3 ml). To further 
address the infection efficacy of different Dp1:Dp2 mixing ratio, we produced and 
purified three different cross-dressed rAAV-hSyn-eGFP viruses, and they were 
tested both in vitro in primary neuron cultures and in vivo in mouse brain. The re-
sults  of rAAV-hSyn-eGFP infection in mouse brain demonstrate that rAAV 
achieves the most efficient infection in brain when cross-dressed with 3:1 of 
Dp1:Dp2 mixing ratio. The production and purification of mouse brain applicable 
rAAV viruses  are the preliminary steps for any further studies  using rAAV in 
mouse brain. The successful establishments of this method brought us the possi-
bility of introducing Tetracycline-Responsive gene expression system into rAAV.
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2.9.3 Titration of rAAV infectious particles
    According to cross-dressing tests, all our rAAV viruses  were prepared in huge 
amounts using slightly modified purification methods (see Materials and Meth-
ods), and the viruses were aliquoted and stored for later use. Infectious particles 
of all the virus stocks were titrated in HEK293 cells, primary neuron cultures and 
in mouse brain, according to the property of the promoter used in rAAV vector, 
respectively. Pictures covering 0.48 mm2 of 3-6 Days-Post-Infection (DPI) culture 
cells were taken, and the total cell number in the picture field is set to ‘NA’, the 
fluorescent cell number is set to ‘MA’, the picture area is ‘A’ and the culture dish 
area is  ‘S’, the applied virus volume is  ‘V’, which was normalized to one micro lit-
ter. The infectious particle number was calculated using equation shown in Figure 
20. In addition to infectious particle titration, Dot-Blot- and Real-Time-PCR-
Analysis  were performed to confirm the results (data not shown). For application 
of rAAV in mouse brain, we adjust the rAAV titer to about 1.0 x 107 particle/µl ac-
cording to previous studies of rAAV immunological consequences (Kuegler et al, 
2001).
 
  Figure 20: Determination of infectious 
rAAV particles in cell culture (here in dis-
sociated primary neuronal culutre; rAAV-
hSyn-itTAnls and rAAV-6p-minibiCre-
tdTomato were titrated). Calculation equation 
is illustrated, with defined factors: MA; S; A.
Results
38
2.10 Combination of transgenic mouse models with recombinant Adeno as-
sociated viruses (rAAV)
    rAAV has  a very small genome size, which dramatically limits the size of the 
delivered transgene. That means  the bulk DNA fragments rendering the promoter 
cell-type- and or tissue-specificity would not fit into the limiting space of rAAV ge-
nome. However, the intrinsic property of the trans-activation systems used for in-
ducible transgene expression brings us  alternative ways to expand the usage of 
rAAV in combination with transgenic mouse technologies.
 
    Figure 21: Schematic view of two alternative combinations of transgenic mouse models 
and rAAV transgene delivery  systems. Transgenic TgThy1.2(xx)-itTAnls (a) and TgCN(xx)-itTAnls  (b) mice 
drives genetically coded tTA expression in the mouse brain. Ptetbi CMV minimal promoters were 
used to simultaneously expression Venus and Cre-recombinase in rAAV-6p-minibiCre-Venus virus 
(c).
   We have generated tTA-expression trangenic mouse lines, such as: 
TgThy-1.2(xx)itTAnls lines (Figure 21 a) (this thesis); CNitTAnls  lines (Kim, 2002); 
TgCaMKII-tTA (Figure 21 b) (Mayford et al, 1996), which show specific promoter 
driven expression of tTA in restricted patterns. Thus, gene expression mediated 
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by rAAV delivered into the transgenic tTA-expressing mice will be restricted in 
cell-type- or brain subregion-specific manner. This will increase the accuracy of 
rAAV application. Furthermore, many well characterized Tet-responsive trans-
genic mouse models are available in the lab, such as: TglacZTETO7gfpGluR-A(SA); 
TglacZTETO7gfpGluR-A; TgGFPTETO7lacZ; MH-CG07; etc. (Figure 22 ). These transgenic 
mice carry Tet-responsive gene cassettes (6-11 kb), which would not be possible 
to put into the rAAV genome. By delivery of rAAV-tTA expressing viruses, we 
would be able to express multiple relatively large genes in rAAV invaded neuron 
populations.
    Figure 22. a: CMV promoter was used to drive itTAnls or rtTAnls expression in rAAV-CMV-
itTAnls/rtTAnls viruses. b: Human Synapsin1 promoter drives itTAnls or rtTAnls expression in 
rAAV-hSyn-itTAnls/rtTAnls viruses. c: Transgenic TgGFPTETO7LacZ mice were used to indicate the 
rAAV delivered tTA induction in the mouse brain.
   Here, we managed by a combination of rAAV, rAAV co-infection and transgenic 
mouse lines, to transfer efficient tet regulated gene expression system into the 
CNS of rodents.
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2.10.1 Deliver rAAV-hSyn-itTAnls into transgenic Tet-responsive mouse 
brains
   First, we asked whether we could induce transgene expression in Tet-responder 
mice by delivering tTA-expressing rAAV viruses. Since the rAAV-hSyn-itTAnls/
nlsrtTAnls viruses were generated and tested as described above, through 
Stereotaxic injection, the rAAV-hSyn-itTAnls viruses were delivered into selected 
brain areas of various Tet-responder mouse brains: TgGFPTETO7lacZ; 
TglacZTETO7gfpGluR-A(SA); TglacZTETO7gfpGluR-A, MTH-IP1 and MTH-Cg2-7. Brain slices 
were analyzed by immunohistochemistry using specific antibodies against GFP 
and tTA. Among the several tetracycline-responsive transgenic lines and MTH-
Cg2-7, only very few cortical and hippocampal neurons showed detectable ex-
pression of reporter gene (GFP or related proteins) after rAAV-hSyn-itTAnls infec-
tion (Figure 23 a-x). These results are best explained by epigenetic gene silenc-
ing of the transgenes. Our data do not exclude that there might be some trans-
gene integration loci still permissive for trans-activation by tTA. However, our data 
suggest that the mosaic reporter gene expression patterns might be due to the 
transgene locus, which happened to be specifically silenced by epigenetic silenc-
ing programs in adult mouse brain.
2.10.2 Epigenetic silencing programs in CA1 and cortical neurons could be 
significantly reversed by long-term itTAnls antagonizing efficacy.
    The permissive loci such as TgLuciferaseTETO7InversePericam (MH-IP1) and TgLuciferase-
TETO7Camgroo2(07) (MTH-Cg2-07) still showed mosaic responder gene expression in 
cortical neurons and in CA1 pyramidal cells, after short-term (14 days) rAAV-tTA 
viruses infection. We hypothesized that high itTAnls  cellular leves  will be able to 
significantly de-silence some populations of neurons in long-term infection. To test 
the idea, rAAV-hSyn-itTAnls virus was delivered into two groups of MH-IP1 mouse 
brains. One group of rAAV-hSyn-itTAnls infected mice were analyzed at 14 DPI. 
The results showed weak reporter gene expression in some cortical- and CA1-
neurons (Figure 24 d-f). However, the other group was analyzed at 75 DPI, which 
showed significantly increased reporter expression intensity, and also in signifi-
cantly increase neuronal populations in cortical- and CA1-neurons (Figure 24 a-
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c). Thus, rAAV could mediate long-term tTA-dependent gene expression in the 
mouse brain, and by delivering rAAV-hSyn-itTAnls, we demonstrated that the epi-
genetic silencing programs in certain neuronal populations could be reversed.
Figure 23. High concen-
tration of transactivator 
could not activate trans-
gene expression in adult 
transgenic reporter 
mouse bra ins . No 
GFPGluR-A expression was 
detected in cortex (c). Very 
few positive neurons were 
stained in CA1 and CA2 
regions (a and b). Strong 
tTA signals were detected 
in the same infected brain 
regions (d-f). 
   Very low GFPGluR-A(SA) 
expression was detected 
in the cortex (g and i), and 
only very few positive neu-
rons in CA1&2 regions (g 
and h); but strong tTA sig-
nals were detected in cor-
responding brain regions 
(j-l).
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  TgGFPTETO7LacZ mice 
showed low GFP expres-
sion in the cortex (m and 
o), and only very few posi-
tive neurons in CA1 region 
(m and n); while strong 
tTA was present in the 
same rAAV invaded brain 
regions (p-r). 
  MTH-Cg2-7 mice 
showed low GFP expres-
sion in the cortex (s and 
u), and also only very few 
positive neurons in CA1 
region (s and t); while 
strong tTA were present in 
the same rAAV infected 
brain regions (v-x).
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    Figure 24. Epigentic silencing effects in cortical neurons of MT-IP01 transgenic mice can 
be released by high cellular itTAnls. After 14 days of infection, only small  numbers of reporter 
positive neurons were detected in cortex and CA1 regions (d-e) of first group MT-IP01 mouse 
brains; At 75 days post infection, significantly increased number of reporter positive neurons were 
detected in cortex and CA regions (a-c).
2.10.3 Deliver rAAV-Tet-responsive viruses into transgenic tTA-expressing 
mouse brains
    We have shown that rAAV-delivered focally elevated transactivator concentra-
tion in transgenic Tet-responder mouse brains could not potentiate transgene ex-
pression. Thus we suppose that the tet-responder transgene itself and its copy-
number determine the expression limits. To test this hypothesis, we developed 
rAAV-Tet-responsive viruses, which harbor Ptet-bi driven dual expression cas-
settes. rAAV-6P-minibi-iCre-Venus recombinant AAV vector was used, which ex-
presses improved Cre recombinase (Shimshek, 2001) and Venus driven by bi-
directional CMV minimal promoters. After delivery of rAAV-Tet-responsive viruses 
into existing tTA-expression transgenic mouse brains, the invaded neuron popula-
tion will be transduced with multi-copies of rAAV Tet-responder genes. Transgenic 
Results
44
tTA mouse lines such as TgThy-1.2(xx)itTAnls, CaMKII-tTA (TgCamKIIα-tTA), CaMKII-
rtTAnls (KM2) and 8.5kbCaMKII-NR2C-itTAnls (TgCN(12)-itTAnls) were studied for ac-
tivation of rAAV delivered genes. Tg(Thy-1.2-itTAnls)64Rsp mice exhibited strong intrinsic 
Venus signals  after infection of rAAV-6p-minibiCre-Venus (Figure 25 a-c). The 
immnofluorescent stainings against Venus and Cre-recombinase showed that 
rAAV-Tet-responder viruses could efficiently and simultaneously express both re-
porter genes, which could be completely abolished upon oral Doxycyline admini-
stration (Figure 25 d-k). 
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    Figure 25. Transgenic tTA mice could achieve different induction efficacy of rAAV-
delivered tet-responsive transgene expression in the rAAV invaded brain regions. rAAV-6p-
minibiCre-Venus was delivered into TgThy-1.2(64)-itTAnls mouse brain. Strong intrinsic  Venus signals 
were observed (a-c); immunofluorescent stainings showed that rAAV delivered Ptetbi could effi-
ciently mediate dual  protein expression in the cortex (d-f) and in the hippocampus (g-i); the re-
porter gene expression was shown under the tight control of Doxycycline (j-k). 
    Figure 26: Weak intrinsic Venus signals were observed, when rAAV-6p-minibiCre-Venus 
was delivered into TgCamKII-tTA mouse brain (a-c); immunofluorescent stainings showed that 
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rAAV delivered Ptetbi could also mediate dual protein expression in the cortex (d-f) and in the hip-
pocampus (g-i); the reporter gene expression was also shown under the tight control of Doxycy-
cline (j-k).
   However, TgCamKIIα-tTA mice, which express less tTA in the forebrain or restricted 
patterns showed only mild Venus  signals at 7-12 DPI after delivery of rAAV-6p-
minibiCre-Venus responder viruses (Figure 26 a-i). These results demonstrated 
that upon super-infection of rAAV-Tet-responsive viruses, neurons contain higher 
concentration of trans-activator-tTA could achieve higher and more efficient trans-
gene induction under the tight control of Doxycyline (Figure 25 j-k and 26 j-k). 
Furthermore, these results show that the rAAV-mediated transgene expression in 
TgThy-1.2(xx)itTAnls mouse brains is specifically restricted in tTA-positive neurons, and 
therefore, a tTA independent expression of rAAV delivered tTA-responder genes 
is  below our method of detection (data not shown). Several other bi-directional 
tetracycline-responsive rAAVs possessing different fluorescent dyes and/or func-
tional proteins, provided similar results (data not shown). Thus the defined ex-
pression pattern and intensity of tTA expression in tTA-expressing transgenic 
mouse lines allow precise targeting of neurons in specific brain subregions. This 
efficient dual-transgene expression of genes is made possible by combination of 
transgenic tTA-expression mouse lines and rAAV-Ptet-bi-responder viruses such 
as rAAV-6p-minibiCre-Venus. Over-expression of multiple genes, such as fluores-
cent markers and and other cellular gene, is now readily achievable.
2.11 rAAV-hSyn-itTA / rAAV-6p-minibi-iCre-Venus could mediate strong in-
ducible transgene expression in vivo, independent of transgenic tTA-
expressing mouse lines
    Combination of rAAV with transgenic mouse models is a powerful tool. How-
ever, for many applications in vitro and/or in vivo, it would be more convenient to 
avoid generation of transgenic mouse models for obvious reasons. Thus, we de-
veloped both tTA-expressing rAAV, and rAAV-tet-responders, which could mediate 
inducible dual-protein expression in neurons. For rAAV shows high coinfection 
efficiency in the mouse brain, co-delivery of multiple dyes or proteins is now pos-
sible. This  is  also important in many Real-Time monitoring studies. Here, we 
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showed the rAAV-Mediated-Tet-Responsive coinfection system, which could ac-
complish co-delivery of as many as 4 proteins simultaneously in neurons. And 
most importantly, the strong expression of the 4 proteins could be synchronized 
by tTA-dependent gene induction.
    Figure 27. rAAV-hSyn-itTAnls / rAAV-6p-minibiCre-Venus coinfection mediated robust 
regulatory gene expression in selected wild-type mouse brain. a-c: Robust intrinsic  Venus 
signal was observed in cortex and hippocampus with infected neurons labeled in their entirety; d-f: 
Gene expression in infected cortical  neurons could be turned off by Dox treatment; g-i: rAAV-tTA/
rAAV-tet-responder mediated gene expression in CA1 neurons is under tight control of Doxycy-
cline. 
   To show that the rAAV-hSyn-itTAnls / rAAV-tet-responder could mediate robust 
expression of Venus, we first did in vitro primary neuronal culture studies by co-
infection of rAAV-hSyn-itTAnls / rAAV-tet-responder viruses. Robust fluorescence 
was observed five days after infection, and most importantly the reporter Venus 
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expression could be efficiently turned off by Dox administration within 7 days 
(data not shown). Thus it will become an important and powerful tool if the rAAV-
hSyn-itTA / rAAV-tet-responder combination could maintain the same induction 
efficacy and could achieve the same strong induction level in vivo in rodents 
brain.
   To prove that rAAV-hSyn-itTA / rAAV-minibi-Cre-Venus viruses could achieve 
robust tTA-dependent gene expression, the two viruses were mixed and injected 
into the wildtype mouse brains. The mice were kept 10 days before analysis. The 
mice were analyzed by immunohistochemistry and Confocal Microscopy (Figure 
27). The results  revealed that rAAV-hSyn-itTA / rAAV-Ptet-bi-genes could induce 
strong reporter gene expression. Most importantly, the reporter gene expression 
could be turned off efficiently by oral administration of Doxycycline in the drinking 
water (Figure 27). Therefore, the rAAV-hSyn-itTA / rAAV-Ptet-bi-genes system 
could be an alternative, efficient and economic tool for tet-regulated gene expres-
sion in the CNS of rodents.
2.12 Leakiness control experiments for rAAV-tet-responsive viruses demon-
strates expression is under tight control of Doxycycline.
     All important features  of the rAAV-tet-responder and/or transgenic tet-
responsive mouse models mentioned above are based on the fact that the bidi-
rectional tetracycline responsive promoters  are under tight control of tTA, which 
could be regulated by Doxycycline administration. To demonstrate this, we deliv-
ered rAAV-tet-responder into wild-type mouse brains  with different concentration 
of infectious virus particles (1: 1; 1 : 10; 1 : 50 and 1 : 100 serial dilutions). No re-
porter could be detected either by immunohistochemistry or by fluorescence live 
imaging using GFP-specific antibodies in the infected mouse brain when the in-
jected virus concentration is lower than 108 particles/ml (75 nl / injection site) 
(Figure 28). These results  demonstrated the tightness of the tet-responsive bidi-
rectional promoters, which could be combined with rtTA expressing rAAV virus to 
conditionally express toxins and dominant negative mutants in the CNS of ro-
dents.
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    Figure 28. To test the leakiness of the episomal state tet-responsive constructs, serial 
dilutions of purified rAAV-6p-minibiCre-Venus were injected into mouse brains in cortical 
neurons. Mouse brains were analyzed by immunostainings using GFP-antibody. rAAV-6p-
minibiCre-Venus (1:1; Volume ratio in 1xPBS) shows mild basal expression of Venus in cortex (a-
c); Ten times dilution of rAAV-6p-minibiCre-Venus (1:10) shows nearly no expression of Venus (d-
f); Fifty- (g-i) and hundred-times (j-l) dilutions of rAAV-6p-minibiCre-Venus show no detectable 
Venus signals.
2.13 Neuronal cells infected with rAAV in Tg(Thy-1.2-itTAnls)64Rsp mouse brain 
can be visualized in vivo by two-photon imaging
   It has shown that rAAV delivered into Tg(Thy-1.2-itTAnls)64Rsp mouse brain could me-
diate intense fluorescent reporter gene expression in apical cortical neuronal 
populations. Here, we demonstrate that the intense fluorescent reporter gene 
products can be visualized in vivo by two-photon microscopy. Tg(Thy-1.2-itTAnls)64Rsp 
mice were infected with rAAV-6p-minibiCre-Venus virus. After 5-7 days, the in-
fected Tg(Thy-1.2-itTAnls)64Rsp mice were anethetized and using the two-photon micro-
scope rAAV infected neurons could be detected in different cortical layers with en-
tire labeling in cell bodies, dendrites and spines (Figure 29 A). Microstructures of 
the infected neurons are clearly visible due to the intense and sparse labeling, 
which reflects the expression features of TgThy-1.2(xx)itTAnls transgenic mouse lines 
mentioned above (Figure 29 B). Furthermore, series of images were also col-
lected either at frequence rates of 5-15 Hz, or at depths of 50 μm of interval with 
cooled-CCD camera.          
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 Figure 29. rAAV infected TgThy-1.2(64)-itTAnls mouse brain was visualized by Two-photon mi-
croscopy. A: ex vivo visualization of Mouse I, green arrow shows the axon of a cell; B: Mouse II 
was in vivo visualized to reaveal the fine structures of cortical  neurons, green arrow shows the 
spines of rAAV infected neuron. 
    The serial pictures taken at different time and/or depth interval were trans-
formed into movie and/or 3-Dimension formats to illustrate the micro-structure 
mobility upon certain stimuli, and to reveal the 3-D structure of infected neurons, 
respectively (data not shown). Thus, the combinatorial system of TgThy-1.2(xx)itTAnls 
transgenic mice and the rAAV has been proven to be a powerful tool for in vivo 
live imaging of micro neuronal anatomical structures and/or study transgene func-
tions in real-time in invaded cortical neuronal populations. (Done in collaboration 
with Dr. Hasan, MT and Dr. Denk, W., MPI for Med. Research, Heidelberg, Ger-
many)
2.14 rAAV infected neurons have normal neuronal electrophysiology.
    rAAV has been shown as an important and powerful alternative method for 
gene delivery in the rodents brain, however, the strong and intense reporter gene 
expression brought the concerns of changing the neuronal properties of the rAAV 
invaded neuron population. Therefore, we asked whether the multiple-rAAV-
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invaded neurons have normal electrophysiological properties. Young wild-type 
mice (P20) were infected by rAAV-hSyn-itTAnls  and rAAV-6p-minibiCre-Venus, 
rAAV-hSyn-itTAnls  and rAAV-6p-minibiCre-tdTomato in hippocampus region, re-
spectively. 
    Figure 30. Electrophysiology  revealed that rAAV invaded CA1 neurons have normal neu-
ronal properties. rAAV-hSyn-itTAnls/rAAV-6p-minibiCre-Venus (Green) and rAAV-hSyn-itTAnls/
rAAV-6p-minibiCre-tdTomato (Red) infected hippocampal CA1 neurons were examined by study-
ing the I/V curve relationship. Neighboring non-infected neurons were patched as wild-type control 
(Black). There is no significant difference among Green, Red and control observed for resting po-
tential, peak amplitude, half width, peak threshold and rise time.
    Seven days post-infection, the infected mice were sacrificed and Venus posi-
tive neurons (5-7) of acute brain slices were patched with neighboring black neu-
rons (6-8) as  wildtype controls to study the neuronal properties. Several basic pa-
rameters, such as resting potential, peak amplitudes  and peak thresholds, etc. 
were recorded. Input-Output curves and statistical studies showed that the 
multiple-rAAV-invaded neurons  have normal neuronal properties in terms of in-
vestigated parameters (Figure 30) (Done in collaboration with Sven Berberich and 
Georg Köhr; MPI for Med. Research, Heidelberg, Germany). 
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3. Discussion:
3.1 Generation of novel tTA-expressing mouse lines.
    The increasing number of tTA-expressing transgenic mouse lines  provide new 
opportunities to investigate the brain functions using reversible gene expression 
system. The experimental data provided by expanding pool of tTA-expressing 
mice will also further help to improve the tetracycline-responsive gene expression 
system in the mouse brain. Although TgCamKIIα-tTA and several other transgenic tTA 
mouse lines were proven to be useful activator lines, they could not achieve over-
expression of many Tet-responder lines. The moderate tTA expression was often 
not suitable for visualizing detailed neuronal sub-structures in vivo. As an impor-
tant and promising tool, we showed that TgThy-1.2(xx)itTAnls transgenic mouse lines 
can be used for various applications of regulated gene expression in the mouse 
brain. TgThy-1.2(xx)itTAnls transgenic mice exhibited robust tTA expression as did sev-
eral other transgenes, which used the Thy-1.2 promoter (Carroni, 1996; Feng, 
2003). 
    In TgThy-1.2(xx)itTAnls/TgGFPTETO7lacZ double positive mice, the trans-activator (tTA) 
and the reporter (GFP or β-galactosidase) could be co-localized in the same neu-
ron. These co-localization studies showed that regardless of tTA levels, the re-
porter can be expressed in high or low levels, and sometimes not at all. This 
shows that the efficiency of reporter gene expression strongly depends on the tet-
responder transgene. This  is supported by the finding that overall expression of 
reporter gene is not significantly potentiated, though quantitative analysis, such as 
Western-Blots, should be carefully performed to confirm this finding. In summary 
our results indicate that the induction efficacy of the transgenic Tet-responsive 
system might be highly dependent on three factors: first, the tTA concentration; 
second, the copy-numbers of the reporter genes; third, the accessibility of the Tet-
responder locus.
    As shown by the Southern-Blots analysis, the intensity of the transgene ex-
pression under certain promoters  is not correlated with copy-numbers, and there-
fore depends on the chromosomal integration site. The analysis of Tet-responder 
integration sites in TgGFPTETO7lacZ, TglacZTETO7gfpGluR-A(SA) and TglacZTETO7gfpGluR-A 
transgenic mice showed that TglacZTETO7gfpGluR-A(SA) has the lowest transgene copy-
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number among the three, but TglacZTETO7gfpGluR-A(SA) shows the strongest transgene 
expression in TgCamKIIα-tTA breedings. Therefore, we studied the expression pat-
tern and intensity of tet-responder genes targeted to the chromosomal insertion 
site of TglacZTETO7gfpGluR-A(SA). 
3.2 Gene tartgeting transfer of single-copy transgene using detected locus.
    By gene targeting, we generated a mouse line with one copy of lacZ-tetO7-
GFPGluR-A (Pik3c3-A1.1) and compared to TglacZTETO7gfpGluR-A(SA), which carry 
three copies of a very similar transgene in the same locus. Upon induction with 
TgCamKIIα-tTA,   TglacZTETO7gfpGluR-A(SA) mice showed robust lacZ and GFPGluR-A(SA) 
expression. However, in Pik3c3-A1.1/TgCamKIIα-tTA mice, β-gal could hardly be de-
tected. The reduced activation of the responder genes might reflect a copy num-
ber dependence. But it is also possible that the neo selection marker gene in the 
targeted locus is attenuating the expression of the tet-responder genes. The re-
moval of the neo selection marker is necessary before conclusions  can be drawn. 
Especially since it is known that single-copy integrant was shown to be successful 
(Bond et al, 2000; Stiw 1999), which also showed that the neo-gene had a nega-
tive effect on the expression level. 
    Next we performed in vivo experiments in the mouse brain to show the epige-
netic silencing effects in cortical neurons can be reprogramed. In the presence of 
neo selection gene, double transgenic Pik3c3-A1/TgCaMKII-tTA and Pik3c3-A1/
ThyF64 mice did not show detectable reporter gene expression in cortical neu-
rons, in which active epigenetic silencing programs were shown by delivery of 
rAAV-6p-minibiCre-Venus virus  into several tet-responder mouse lines. However, 
after removal of neo gene specifically in selected cortical neuron populations by 
rAAV-6p-minibiCre-Venus virus injection, we showed that tTA expressed from 
Thy-1.2-itTAnls minigene cassettes successfully induced tTA-dependent gene ex-
pression of targeted nlacZ-tetO7-GFPGluR-A responder cassette in Pik3c3 locus. 
Therefore, consistent with previous in vitro studies  mentioned above, we demon-
strated that epigenetic silencing effects or promoter competition in cortical neu-
rons of rodent brains can be reprogrammed.
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3.3 Epigenetic silencing strongly influences the integrated Tet-responsive 
transgene cassettes in the mouse brain
     It is  well known that two independent founders carrying the same copy number 
of the same transgene constructs still show significant difference both in expres-
sion patterns and intensity. This reflects the profound effects of genomic loci. Re-
search in Drosophila using Enhancer-Trap (Wilson, et al, 1990) and/or P trans-
poson (Levis et al, 1985; Hazelrigg and Petersen, 1992; Zhang and Spradling, 
1994;) demonstrated the position effects in invertebrates. Transgenic vertebrate 
model also showed that transgene suppression could be an intrinsic property 
evoked by repeated transgene constructs  (Flavell, 1994; Rossignol and 
Faugeron, 1994;). This  suggests that Histone H4 lysine residue deacetylation and 
coincident condensation of chromatin structures are underlying gene silencing of 
both transgene and virally transduced delivery of genes  (Chen and Toweens, 
2000). In our studies described before, by introducing tTA-expressing rAAV into 
several Tet-responder transgenic mouse lines, we demonstrated that epigenetic 
silencing effects  strongly influence the expression of integrated tTA-dependent 
transgene expression. And also, double transgenic Pik3c3-A1/ TgCamKII-tTA and 
Pik3c3-A1/ThyF64 mice failed to show reporter gene expression with the pres-
ence of neo-selection gene, which might hinder the gene expression by epige-
netic silening in Pik3c3 locus. But results also showed that CG19 locus is permis-
sive to tTA transactivation in the adult mouse brain, while in all the others, includ-
ing TglacZTETO7gfpGluR-A(SA) mice, no transgene expression was detectable (Figure 
31) (Zhu, et al, 2006). This  showed that there is rare permissive locus existing in 
Mus musculus genome, although most of the loci are vulnerable to gene silencing 
effects in adult mouse brain. Yet, the activation of the permissive locus of TgLucife-
raseTETO7Camgroo2(19) (MTH-CG19) needs relatively high cellular tTA concentration 
(this thesis and Zhu et al, 2006).
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    Figure 31: High concentration of tTA delivered by rAAV-hSyn-itTA can induce reporter 
gene expression in MT-CG19 transgenic mouse brain. Reporter gene: Camgroo2 was visual-
ized by GFP antibody in cortical neurons and CA1 hippocampal neurons (a); High concentration 
of tTA was stained using tTA antibody in the same regions of neighboring slices (b).
    Interestingly also, studies found that LCR-derived specific insulator sequences 
could increase the possibility of efficient transgene and retroviral expression, 
seemingly regardless of chromosomal integration sites (Rivella et al, 2000). Pre-
liminary studies from our lab using insulator elements in tet-responder mice failed 
to improve the tet regulated gene expression. Different Human Insulator 40 
flanked tet-responding transgenic mice bred with the same tTA-expressing mouse 
lines: TgCamKIIα-tTA and/or TgThy-1.2(xx)itTAnls showed that the cellular expression is still 
strongly influenced by the chromosomal integration site (Krüth, U. unpublished 
data). 
    Thus it remains hard to achieve stable transgene expression in the mouse, es-
pecially in the CNS. 
3.4 Episomal rAAVs could overcome the epigenetic silencing effects. 
     Work using retroviral vector transferred rtTAnls-mediated inducible transgene 
expression was successful in the CNS of rodents (Szulc et al, 2006). However, 
dual-inducible transgene over-expression using both tTA and rtTAnls was chal-
lenging. Here, we showed that we achieved fast, strong and dual-inducible trans-
Discussion and Conclusion
56
gene expression using rAAV and the combination with retroviral vectors and 
transgenic mouse lines. Since we have showen that rAAV could maintain strong 
gene expression for at least 75 days  in the mouse brain, focal expression using 
rAAV mediated gene transfer is  no longer an issue. To investigate the roles of 
bigger brain regions, rAAV has to be delivered into selected brain regions by 
micro-injection into the P0-P2 young mice and/or rats brains (work in progress). 
Since rAAV-mediated transgene expression is  stable for at least 6-8 months in the 
mouse brain (Kuegler et al, 2003), the P0-infected-mice will be expected to have 
large brain region infected when the animal is 4-8 weeks  in age. In principle, this 
might achieve rAAV-tTA / rAAV-Tet-responders-mediated, rAAV/retroviral-vectors-
mediated and rAAV / transgenic-mice-mediated dual-transgene expression in 
large brain regions. 
     However, the large region and long-term infection of rAAV and its  combination 
retroviral vectors require extremely low neurovirulence effects in the rodents CNS 
to be used for physiological studies. This  raises the question of how the virus 
titers could be increased, but without eliciting immune responses by activation of 
microglia cells  in the CNS. We have managed the purification of high-titer rAAV 
stocks, which did not show any detectable neurovirulence effects within 6 weeks 
in the mouse brain (data not shown).
3.5 Combination of transgenic mice, retroviral vectors and rAAV systems 
   By injecting rAAV-6p-minibiCre-Venus into the brain of tTA expressing trans-
genic mice (Tg(Thy-1.2-itTAnls)64Rsp), we observed a high co-localization rate of Venus 
and Cre, which indicates the efficient transactivation of rAAV-delivered genes in 
the adult mouse brain. More importantly, the rAAV-6p-miniCre-Venus expression 
was restricted only in Tg(Thy-1.2-itTAnls)64Rsp tTA-positive cells, and therefore strictly 
dependent on the Tg(Thy-1.2-itTAnls)64Rsp tTA-expression pattern. This combination 
could also be used for fast screening of the newly generated tTA expressing 
transgenic lines in desired brain regions.
3.6 rAAVs can achieve transgenic mouse independent Tet-responsive gene 
expression
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    However, transgenic mice are an expensive and time-consuming method for 
most of the laboratories. Now, we have shown that rAAV are powerful tools for 
gene delivery in rodents brain. rAAV showed high coinfection efficiency and long-
term non-toxic stable gene expression in vivo. Combining rAAV-tet-responder and 
rAAV-tet-activators make the rAAV a transgenic mouse independent gene delivery 
system. However, there is  always shadow in the sun: the intrinsic property of the 
rAAV limits the packaging capacity of transgenes, the diffusion of the viral parti-
cles is  too large (>1.5 mm in diameter), etc.. Different promoter driven tTA-
expressing transgenic mouse models showed cell-type- and/or brain-suregion-
specific expression of tTA, which is very important for inducible transgene expres-
sion in certain cell types or special brain regions. The small size of rAAV genome 
is  not enough to package most of the promoter fragments used for specific ex-
pression, and also the small size of the rAAV particles renders huge diffusion di-
ameters, which would cover more than one specific brain subregions. To over-
come this  issue, we also tested the combination of retroviral vectors, such as 
lenti-expression system, which has  much bigger cloning capacity and would 
therefore compensate the rAAV system in delivering huge promoter DNA frag-
ments. Lenti-CaMKII-tTA was made and injected together with rAAV-6p-minibiCre-
Venus into the adult mouse brains. After 7-14 DPI, the mice were shown to have 
strong Venus expression in CaMKII-positive cells. Also other neuron specific pro-
moters  were cloned into lenti vectors and tested successfully (data not shown). 
These experiments demonstrated that the combination of retroviral vectors and 
rAAV could achieve cell-type-specific strong expression of reporter genes. This 
makes the rAAV-Tet-responder viruses a powerful tools  in labeling, and express-
ing transgenes in desired neuron populations in the adult mouse brain.
3.7 Conclusions
    We have generated novel tTA-expressing TgThy-1.2(xx)itTAnls transgenic mouse 
lines which show strong tTA-dependent expression of Tet-responsive genes in dif-
ferent neuronal populations and brain subregions, including cortical layer 5. 
These mouse lines, together with the previously described lines, would facilitate 
correlation of reversible gene expression in specific neuronal cells to phenotypes. 
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Clearly, stable transgenic lines are vital research tools as  they also allow for re-
producible spatiotemporal gene expression and thus are extremely useful for 
long-term biological studies, including learning and memory and diseases. The 
ability to utilize various  cell type specific tTA-expressing mouse lines , including 
those generated by BAC, will facilitate targeted expression of any gene in specific 
cell types in selective brain subregions  when combined with rAAV harboring Tet-
responsive elements.
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4. Materials and methods
4.1 Construction of Thy1.2-itTA Plasmids:
   The Thy1.2-itTA plasmid was generated by genetically combining two plasmids: 
pBS.itTApA and pmThy1-PL (mouse Thy1-PolyLinker). Due to the intrinsically na-
ture and sensitivity of the Thy1.2 expression cassette, only the congenital enzyme 
restriction sites were used. The 1.0 kb itTA was released from pBS.itTApA by ClaI/
SacII double digestion. And pmThy1-PL plasmids was linearized into two pieces 
by MluI, XbaI and ClaI. The DNA fragments were cleaned by Gel-Purification (QI-
AGEN, Germany) and ligated at 16°C (Ligase; ROCHE, Germany). After trans-
formation and screening of the clones, the plasmids were verified by enzyme di-
gestion and sequencing.
4.1.1 Generation of Thy1.2-itTA transgenic mice:
   The pmThy1.2-itTA plasmids were prepared in large amount using HiSpeed 
Maxi-Prep. Kit (QIAGEN, Germany) and cleaned by Phenol/Chloroform Extrac-
tion. Then the DNA was fully digested by NdeI/NotI (Fermentas, Germany). The 
digested DNA was concentrated by Isopropanol precipitation and resolved in 
1xTE buffer to 1.0 μg/μl. 10 μg of linear DNA of Thy1.2-itTA (8.5 kb) were sepa-
rated by sucrose density gradient centrifugation in a Beckman L8-70M ultracentri-
fuge using an SW40T rotor (10 % - 40 % sucrose, 35,000 rpm, 16 h at 15 ℃). 
The 200 μl gradient fractions were checked on 1.0% agarose gel. Appropriate 
fractions containing the minigenes without vector backbone were purified by Ami-
con Micron 50 Filters (Millipore). Pronuclear-Injection was done by Zentral Labor 
im NeuheimFeld (ZTL), Heidelberg, Germany.
  
4.1.2 Genotyping of transgenic Mouse lines by tail-PCR 
    Mouse tails  from (age P10-P14) different transgenic mouse lines were digested 
with Proteinase K (1 mg/ml) in TENS-Buffer (50 mM Tris- HCl pH=8.0, 100 mM 
EDTA, 100 mM NaCl, 1 % SDS) at 55 °C for 8-12 hours. After precipitation by 1 
volume of isopropanol and washing with 70% ethanol, the genomic DNA was re-
solved in 100-300 μl water. Genotyping PCRs were setup in 25 μl reactions, con-
taining PCR-buffer (GibcoBRL), 2 mM MgCl2, dNTP-Mix (0.2 mM pro Nucleotide), 
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specific sense- and antisense-oligonucleotide (each 0.4 μM), 0.2-0.5 U Taq-
Polymerase, ddH2O and 1μl Template-DNA-solution (10-100 ng/μl). PCR pro-
grams were as following:
Thermo-Cycles Temperature and Time
1cycles: 94°C    10 min
30 cycles:
94°C    15 sec
55-58°C    15 sec
72°C    15-50 sec
72°C for an additional 7 min after the final cycle.
   PCR amplicons were checked on 1.5-3.0% agarose gel. The results were 
evaluated according to special designs.
-- A1.1: VM4; GluRA-VM4 (Tg: 350 bp) 
-- G3:  lac3’, lac5’ (lac: 500 bp)
-- GluR-A-1lox: 1005; 3’intro3; 1Lox-PZ (wt: 180 bp; het: 180 bp and 250; 
hom: 250 bp)
-- LC1: rspCre1, rspCre2 (Cre: 200 bp) 
-- KT1: tTA1; tTA4 (tTA: 350 bp) 
-- Pik3c3-A1: FP-SA-400; Hgh04 (Tg: 550 bp)
-- RLZ:  lac3’, lac5’ (lac: 500 bp) 
-- SA87.5:  FP-SA-400; Hgh04 (Tg: 700 bp) 
-- Thy1b: Th1-tTA-FP; Thy1-tTA-RP (wt: 500; Tg: 300 bp) 
4.2 X-gal staining for vibratome sections 
    Brains were removed and fixed for 2 h in 4 % Parformaldehyde in PBS (137 
mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4/2H2O, 1.4 mM KH2PO4). Afterwards the 
brains were rinsed wit PBS, embedded in 2.5% agarose (Seakem LE) in PBS and 
cut sagittally or coronally in 70-80 μm sections on a vibratome (Leica VT 1000S, 
Leica). The sections were incubated for 5-60 min at room temperature in X-Gal 
staining solution (5 mM K4Fe(CN)6, 5 mM F3Fe(CN)6, 2 mM MgCl2, 2 mg/ml X-Gal 
in dimethylformamid/PBS). Sections were washed twice in PBS and once in 10 
mM Tris/HCl, pH=7.6. Sections were immediately counter-stained with eosin 
(Sigma) for 1 min and rapidly and successively dehydrated in ethanol 70, 90, 99.5 
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% (v/v). The dry sections  were dehydrated in Xylene and embedded in EuKitt 
(Kindler GmbH, Germany). 
4.3 Immunocytochemistry (ICC) 
     Mice were anesthetized with lethal dose of halothane (Hoechst, Germany) and 
intracardially perfused with phosphate-buffered saline, pH=7.4 (PBS), at room 
temperature followed by ice-cold 4 % paraformaldehyde (PFA) in PBS. Brains 
were removed and post-fixed for 1 h in PBS containing 4 % PFA at 4℃. After-
wards the brains were rinsed with PBS and embedded in 2 % agarose in PBS 
and cut sagittally or coronally in 80 μm sections on a vibratome (Leica VT 1000S; 
Leica, Germany). For blocking of endogenous peroxidase, sections were incu-
bated for 10 min in 0.5 % H2O2/PBS and washed twice for 10 min with PBS. Sec-
tions were permeabilized in Day 1 buffer (0.3 % Triton X-100, 1 % bovine serum 
albumine (BSA), 3 % normal goat serum in PBS) and incubated overnight in 
buffer 1 containing anti-β-galactosidase rabbit IgG (1:6000; ICN, Germany). The 
following day, sections were washed twice for 10 min in Day 2 buffer (0.1% Triton 
X-100 and 0.3 % BSA in PBS) and incubated for 2 h in Day 2 buffer supple-
mented with peroxidase-conjugated anti-rabbit IgG (1:600; Vector Laboratories, 
USA), washed 5 times, 10 min/time in Day 2 buffer , twice for 10 min in PBS. The 
staining reaction was  developed using 20 mg Diaminobenzidine (DAB; Sigma) 
dissolved in 50 ml of 20 mM Tris/HCl pH7.6 and stopped in PBS. After a brief 
rinse sections were mounted Eukitt (Kindler GmbH, Germany).
4.4 Doxycycline Administration to mice 
   Doxycycline hydrochloride (Sigma) at a concentration of 50-2000 μg/ml, sup-
plemented with 1-5 % sucrose, was dissolved in drinking water and provide to the 
parental mice in light-protected bottles. Animals were kept under doxycycline from 
P1 and until P21 (or P42). At P21 doxycycline was removed from the drinking wa-
ter. For special applications in recombinant Adeno associated virus Chapter, the 1 
mg / 100μl PBS C4-Doxycycline (Hasan, et al., 2006) was IP injected 2 hours, 4 
hours, 8 hours, 24 hours and 72 hours before analysis, respectively.
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4.5 Detection of transgene integration site in mouse genome
4.5.1 Preparation of genomic DNA from liver tissue
   The correctly genotyped mouse was anesthetized by lethal dose of Isofloran 
(Sigma, Germany), then 10-20 grams of liver tissue was cut off and placed on ice-
cold glass carrier. The tissue was then fragmented into small pieces by blade and 
transferred by blunt-tipped sterile plastic pipette tip into 15 ml Falcon-tube (Ger-
many) filled with 8.0 ml TENS buffer  and 1.0 ml of Proteinase K (CloneTech, 
Germany). Digest the tissue at 55°C with gentle shaking for 4-6 hours, and add 
another 1.0 ml Proteinase K, and further digest overnight. The next morning, the 
mixture was transferred into a new 50.0 ml Falcon tube, and the same volume of 
Phenol (Roti-Phenol, ROTH Corp.) was added, the 2-phase mixture was gently 
shaken for 10-30 min at room temperature (RT). Centrifugation was subjected to 
separate the 2 phases at 3000 rpm for 5 minutes  at room temperature. The water 
phase was transferred into another new 50.0 ml Falcon tube. And the same vol-
ume of Chloroform (ROTH, Germany) was added and gently shaken for 5-10 
minutes at room temperature. The mixture was spin down at 3000 rpm for 3 min-
utes at room temperature, and transfer the water phase to a new 50.0 ml Falcon 
tube. 2.5 volume of 100% ethanol was added and gently inverted 4-6 times, and 
spool the genomic DNA by fire-sealed glass capillary. The spooled genomic DNA 
was washed by 70% ethanol for 2-3 times and air-dried for 5-10 minutes at RT. To 
resolve the genomic DNA, 2.0 – 5.0 ml 1xTE (pH=7.8) buffer was  added and in-
cubated at 37°C for 1 hour. After the genomic DNA is fully resolved, add 100-300 
μl of RNase-1 into the solution and let digest for 1-2 hours at 37°C to remove all 
the RNA. 
　 Before embarking on library construction, the size and the purity of the ge-
nomic DNA were checked on 0.7-1.0 % agarose/EtBr gel. 1 μl of purified genomic 
DNA (about 0.1-0.2 μg/μl) and 1 μl of control genomic DNA (0.1 μg/μl) were 
loaded on 0.7% agarose/EtBr gel in 1xTBE buffer, along with 1.0 kb and 20.0 kb 
DNA-ladder size marker (NEB, Germany). Genomic DNA should be bigger than 
50 kb with minimum smearing. And the quality was also checked by Dra I diges-
tion: 5 μl purified genomic DNA; 16 units of Dra I restriction enzyme; 2 μl 10x re-
striction buffer for Dra I; 11.4 μl deionized water; a control digestion without Dra I 
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enzyme was also set-up. Reaction was mixed gently by inverting the tube. Incu-
bate the reaction solution at 37°C overnight. The second morning, run 5 μl of 
each reaction on a 0.7% agarose/EtBr gel along with 0.2 μg of purified uncut ge-
nomic DNA as a control. A smear should be seen, indicating that the genomic 
DNA was digested well by the restriction enzyme.
    For each library construction, 3-5 reactions were set up for the purified genomic 
DNA, and set up one Pvu II restriction enzyme digestion of human genomic DNA 
as a positive control. Label 3 to 5 1.5 ml Eppendorf tubes, and one positive con-
trol.  The digestion was set up by mixing a Master Mix in a separate 1.5 ml tube: 
2.5-5 μg of genomic DNA; 20 μl 10x restriction enzyme buffer; 10-20 units of re-
striction enzyme; fill with de-ionized water to 200 μl. Mix gently by inverting the 
tube. Incubate the reaction at 37°C for 2 hours and then shake the reaction at 
750-1000 rpm for 20 sec, then add another 5-10 units of restriction enzyme, let 
digest overnight. The next morning, run 5 μl of each reaction on a 0.7% agarose/
EtBr gel along with 0.2 μg of purified uncut genomic DNA as a control.
    The digested genomic DNA must be purified by Phenol-Chloroform, so that a 
high efficient 
library could be 
ac hived. To 
each reaction 
tube, add an 
equal volume 
(95 μl here) of 
phenol, and 
vortex at low 
speed for 5-10 
s e c . S p i n 
briefly to sepa-
rate the aque-
ous and or-
ganic phases. 
Then use a pi-
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pette to transfer the aqueous layer into a fresh 1.5 ml Eppendorf tube. Discard the 
organic phase properly into the chlorinated hazardous waste. To each tube, add 
an equal volume (95 μl here) of chloroform, vortex at low speed for 5-10 sec. Spin 
briefly to separate the aqueous and organic phases. And use a pipette to transfer 
the upper layer into a new 1.5 ml Eppendorf tube. Discard the organic layer prop-
erly into the chlorinated hazardous waste.  2 volumes of ice-cold 100% ethanol 
and 1/10 volume of 3 M NaOAc (pH=4.5) was added to each tube. Vortex at low 
speed for 5-10 sec. And centrifuge at 13,000 rpm for 20 minutes  at 4°C. Decant 
supernatant and wash the pellet in 300 μl ice-cold 70% ethanol. And centrifuge at 
13,000 rpm for 5 minutes at 4°C. Then the supernatant was decant and dry the 
pellet in speed-vacuum for 5 minutes at room temperature. The DNA pellet was 
resolved in 20 μl of 1xTE (10/0.1, pH=7.5), and vortex at low speed for 5-10 sec. 
Then spin down the liquid. Remove 1 μl out of each reaction tube, and load on a 
0.7% agarose/EtBr gel to determine the approximate quantity of DNA after purifi-
cation.
4.5.2 Generation of Ligation-Mediated Genomic-DNA-GenomeWalker®-
Adaptor Libraries:
    For each library construction, we set up 4-6 ligation reactions (3-5 digested ge-
nomic DNA, 1 positive ligation control). From each tube, transfer about 0.5 μg 
(volume should be less than 4 μl) of digested, purified DNA to a fresh 0.5 ml tube. 
To each, add the following: 1.9 μl GenomWalker® Adaptors (25μM); 1.6 μl 10x 
ligation buffer (Roche); 5 units T4 DNA ligase (Roche). Incubate the ligation reac-
tion at 16°C on Thermo-Cycler (ABI 9700) overnight. And programmed the ma-
chine to stop the ligation reaction by heating the reaction up to 70°C for 5 min-
utes. To each tube, add 72 μl of 1xTE (10/0.1, pH=7.5), vortex at low speed for 5-
10 sec. And spin down briefly.
4.5.3 PCR-based Genome Walking in Ligation-Mediated Genomic-
DNAGenomeWalker®-Adaptor Libraries:
    Prepare master mix as following (one reaction): 2.5 μl 10x Roche Expand Long 
Template PCR buffer1; 1 μl dNTP; 1 μl Adaptor Primer 1 (10 μM) (or PCP1: posi-
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tive control primer 1); 5 units Roche Expand Long Template PCR Polymerase 
Mix; 1 μl Gene Specific Primer 1; 1 μl each genomic-adaptor DNA library (includ-
ing the positive control and negative control (no DNA template)); 18.5 μl de-
ionized water. After transfer of the reactions into each tube and mix gently by pi-
pette up and down, place caps firmly on tubes, and briefly spin tubes in a micro-
centrifuge. Commence cycling in the ABI DNA Thermo Cycler 9700 using the fol-
lowing 2-step cycle parameters:
Thermo-Cycles Temperature and Time
-5 cycles: 94°C    25 sec
72°C    3-5 min
-30 cycles: 94°C    25 sec
67°C    3-5 min
-67°C for an additional 7 min after the final cycle.
Secondary PCR was set-up by preparing master mix as following (one reac-
tion): 2.5 μl 10x Roche Expand Long Template PCR buffer1; 1μl dNTP; 1μl Adap-
tor Primer 2 (10 μM) (or PCP2: positive control primer 2); 5 units Roche Expand 
Long Template PCR Polymerase Mix; 1μl Gene Specific Primer 2; 1μl each pri-
mary PCR reaction (including the positive control and negative control (no DNA 
template)); 18.5 μl deionized water. After transfer of the reactions into each tube 
and mix gently by pipette up and down, place caps firmly on tubes, and briefly 
spin tubes in a micro-centrifuge. Commence cycling in the ABI DNA Thermo Cy-
cler 9700 using the following 2-step cycle parameters: 
Thermo-Cycles Temperature and Time
-5 cycles: 94°C    25 sec
72°C    3-5 min + 5 sec
-30 cycles: 94°C    25 sec
67°C    3-5 min + 5 sec
-67°C for an additional 7 min after the final cycle.
Add 5 μl 6x loading buffer into 25 μl PCR reactions, and analyze the products 
on 1.5% agarose/EtBr gel, along with DNA 1.0 kb and 20.0 kb size markers. Nor-
mally 30 cycles are enough to have enough PCR products  for sequencing after 
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agarose gel purification, but sometime 5 additional cycles are necessary to yield 
enough PCR DNA products. Positive PCR bands were Gel-purified using QIA-
quick Gel Extraction Kit as  described below: Excise the DNA fragment from the 
agarose gel with a clean, sharp scalpel. Minimize the size of the gel slice by re-
moving extra agarose. Weigh the gel slice in an Eppendorf 1.5 ml tube. Add 3 
volumes of Buffer QG to 1 volume of gel (100 mg ~ 100 μl). For > 2% agarose 
gels, add 6 volumes of Buffer QG. The maximum of the gel slice per QIAquick 
column is 400 mg; for gel slices > 400 mg, and for more than 10 μg DNA use 
more than 1 QIAquick column. Incubate at 50°C for 10 min, with vortexing every 3 
min during incubation. Gel slice have to be completely solubilized. For > 2% gels, 
we increased Buffer QG as mentioned above, and increase incubation time. After 
gel slice has dissolved completely, check the color of the mixture is yellow (similar 
to Buffer QG). If the color of the mixture is  orange or violet, add 10 μl of 3 M 
NaAc, pH 5.0, and mix. Add 1 gel volume of isopropanol to the sample and mix. 
This  step only slightly increases the yield of DNA fragments smaller than 500 bp 
or bigger than 4.0 kb. Transfer the mixture to a QIAquick spin column, which is 
placed on a provided 2 ml collection tube. And centrifuge for 1 min at 13,000 rpm. 
Discard the flow-through and place QIAquick column back in the same collection 
tube. To remove the contaminants, add 0.75 ml of Buffer PE to QIAquick column 
and centrifuge for 1 min. DNA used for salt sensitive applications, such as direct 
sequencing, let the column stand 2-5 min after addition of Buffer PE, before cen-
trifuging. Discard the flow-through and centrifuge the QIAquick column for an ad-
ditional 2 min at 13,000 rpm. Place QIAquick column into a clean pre-labeled 1.5 
ml Eppendorf tube. To elute DNA, add 20 μl of Buffer EB or H2O to the center of 
the QIAquick membrane, let stand for less than 1 min, and then centrifuge the 
column for 1 min at 13,000 rpm.
      The purified PCR amplicons were then subjected to sequencing reactions. Set 
up 20 μl sequencing reactions by combining the following reagents  in a 0.5 ml 
PCR tube: 8 μl BigDye sequencing Mix (CloneTech, Germany); 5-10 μl eluted 
PCR products; 1 μl sequencing primer (10 μM); 6-1 μl deionized water. Mix by 
pipetting up and down several times. Then place caps firmly on the tubes. Com-
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mence cycling in the ABI DNA Thermo Cycler 9700 using the following 3-step cy-
cle parameters:
Thermo-Cycles Temperature and Time
-1 cycles: 96°C    3 min
-5 cycles: 94°C    15 sec
55°C    15 sec
      60°C    4 min
-60°C for an additional 7 min after the final cycle.
   Immediately before the PCR program finished, prepare and label the same 
number as set-up reactions of tubes  on the SIDE of the tube. After the PCR is fin-
ished, transfer the PCR reactions  into each labeled tube. To each tube, add 2.5 
volumes of room temperature 100% ethanol, 1/10 volume of 3M NaOAc (pH=4.5). 
and vortex briefly at low speed. And centrifuge at 13,000 rpm for 20 minutes at 
room temperature. Decant supernatant and wash the pellet carefully in 300 μl 
room temperature 70% ethanol. And centrifuge at 13,000 rpm for another 5 min-
utes at room temperature. Discard supernatant and completely dry the pellet in 
speed-vacuum for 5 minutes at room temperature. Send the tube for sequencing. 
Sequencing data got at the second day and analyzed using LaserGene programs.
4.6 Southern-Blots analysis on Genomic DNA:
    DNA from tissue (tail, liver or brain, etc.) was isolated and purified by prote-
inase K digestion and phenol-chloroform purification described above. Resolve 
the pellet DNA in water (or TE buffer), and measure the concentration in pho-
tometer at 600 nm using BioPhotometer (Eppendorf, Germany). All the DNA sam-
ples were adjusted to concentration of 0.5-1.0 μg/μl. DNA was then digested by 
properly selected restriction enzymes to generate DNA fragments, which will indi-
cate the target bands hybridized by southern-probe(s). Depends on the positions 
of the probes, we performed two hybridization experiments  on the digested DNAs: 
Inner-probe hybridization and Outter-probe hybridization.
    Inner-probe hybridization: the restriction enzymes were chosen to cut within the 
known DNA sequences (or constructs) at least twice, and the probe was designed 
to hybridize onto one of the known DNA fragments so that they will generate at 
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least one DNA fragments band of known-size. The bands pattern of inner-probe 
hybridization will tell us the copy numbers of the known DNA sequences (or con-
structs), and tell us the full-digestion of the DNA samples. Outter-probe hybridiza-
tion: the restriction enzymes were chosen to cut ONCE within the known se-
quences (or constructs), and cut also in the genomic sequence outside of the 
known sequences (or constructs). And this  will generate one un-known size DNA 
fragment, and the probe was designed to hybridize onto the known region of the 
unknown DNA fragments. The bands pattern of outer-probe hybridization will  tell 
us  not only the copy numbers of the know DNA sequences (or constructs), but 
also the numbers of the loci, in which the known DNA sequences (or constructs) 
have been integrated (A.L. Joyner).
    Separation of digested DNA fragments  on agarose gel: 0.7-1.0% agarose gel 
(without Ethidium-Bromide(EB)) was used to separate the DNA fragments. After 
the gel was cool down, pull out the combs in 1x E-buffer in the gel-chamber. Load 
the DNA samples (at least 10 μg DNA with loading dye) following the DNA-size 
marker. Set up the running conditions: 25 volts; about 20 hrs; (or 90 volts; about 6 
hrs; changing buffer every 2 hrs). After running, stain the gel in EB-solutions for 7-
15 minutes, with gentle shaking. Take a picture with proper exposure time and 
magnification scale and the ruler should be included. Leave the EB-stained gel 
under UV light, expose for 10 minutes to generate DNA double-stand breaks. Put 
the gel into Denaturing-Buffer (1 M NaOH) for 30 minutes with gentle shaking, 
and then rinse the gel with Renaturing-Buffer once, and put into the Renaturing-
Buffer for 30 minutes with gentle shaking. Place the gel on pre-soaked 3-4 layers 
of WHATMAN paper (Whatman, Germany), which was placed on a ‘Bridge’ over 
the 20 x SSC pool. Rinse the membrane (Cellulose porablot Nyamp (Macherey-
Nage Nr. 741 200.)) first with Mili-pore water (Mili-pore, Germany), then with 
10xSSC buffer. Place the membrane on the gel, and push out the air bubbles. 
Seal the sides with parafilm (or fresh folie). Add 4-layers  of 10 x SSC pre-soaked 
WHATMAN paper on top of the membrane, and chase out the air bubbles. Add 
another 3-cm-thick dry WHATMAN paper on top and another 3 cm-thick dry paper 
towels.  Place a weight of about 500 gram on top. Leave the blotting setup over-
night (at least 16 hrs, not longer than 20 hrs.). The next morning disassemble the 
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blot tower, and wash the membrane in 5xSSC buffer twice for 10 minutes, and air-
dry. Cross  link the DNA onto the membrane by 2 times UV-light automatic cross-
linking (Strategene).
    The membrane was then Pre-hybridized. Quick-Hyb. Solution (QIAGEN) was 
used for hybridiztion. Gently shake the Quick-Hyb. Solution before use. For 250ml 
hybridization tube, 30 ml of hybridization solution (0.5% SDS of final concentra-
tion; 0.5 ml Salmon Sperm DNA; about 30 ml Quick Hyb. solution) was used. Put 
the pre-hybridization tube into the rotor-incubator before it got warmed-up to 
68°C. Pre-hybridize the membrane in the solution for 1 hour. At the same time, 
label the probe in Radio-Active lab. PCR amplified probes were labeled using Ra-
dom Primed DNA labeling Kit (ROCHE). Pipette 100 ng DNA into a new screw-
cap 1.5 ml tube, and add water to a final volume of 9 μl. Boil the DNA at 95°C for 
10 min. After boiling. Put the DNA immediately on ice, and add the following solu-
tions: 1 μl dATP; 1 μl dGTP; 1 μl dTTP; 2 μl Radom Primer and Buffers; 5 μl [P32] 
dCTP; 1 μl Klenow Enzyme. Vortex the mixture and leave it at 37°C for 45 min. To 
stop the labeling reaction, put the reaction tube on ice and add 2 μl 0.2 M EDTA, 
and then add 80 μl 1xTE buffer, mix gently on ice. To purify the labeled probe, 
prepare a purification column (QIAGEN). Resuspend the column and remove the 
air bubbles, let the column drain at gravity for 10 min over a 2 ml tube. And centri-
fuge the column at 1000 rpm for 4 min to remove the solution completely. Place 
the column onto a new 1.5 ml Eppendorf-tube and apply the reaction mix into the 
middle of the column, and centrifuge at 1000 rpm for 4 min. Pipette 1 μl of the la-
beled DNA into a new 1.5 ml Eppendorf-tube, and determine the radio-activity. 
The probe’s radio activity should be higher than 1x108 cpm/g DNA.
    Following pre-hybridization, hybridization of the membrane was performed. Mix 
the labeled probe DNA with 200 μl Salmon Sperm DNA, and boil the mixture at 
95°C for 10 min in a screw-cap Eppendorf-tube. After boiling, take the pre-
hybridization tube out of the incubator and pipette 500 μl solution into the probe, 
mix on ice and then transfer the probe into the hybridization tube. Shake the hy-
bridization solution very well and put the hybridization tube back into the incuba-
tor. Hybridize the membrane for 1 hour at 68°C. After hybridization, wash the 
membrane with RT washing buffer (0.1 x SSC and 0.1 x SDS) briefly. Then add 
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20 ml washing buffer into the tube, wash the membrane twice with gentle rotating, 
each time 15 min. then wash the membrane once in 55°C washing buffer for 15 
min. if necessary, wash the membrane once more at 55°C. Wrap the membrane 
into fresh folie, and put an illuminant ruler marker beside the sample loading slots. 
Expose the membrane in the cassette for 12 hours at -70°C, and develop the film 
(ECL, Kodak) in the next morning.
4.7 Real-time PCR analysis:
    The real-time PCR system is based on the detection and quantitation of fluo-
rescent probes , which bind specifically onto defined regions of templates  se-
quences. The TaqMan probes (Heid, et al. 1996) and molecular beacons  (and 
more recently, scorpions) use the fluorogenic 5' exonuclease activity of Taq po-
lymerase to measure the amount of target sequences in DNA samples. TaqMan 
probes are oligonucleotides, which are usually designed to be longer than the 
primers (20-30 bases long with a Tm value of 10 ℃ higher) . The probe oligonu-
cleotides carry a fluorescent dye on the 5'-end, and a quenching dye (TAMRA) on 
the 3'-end. Laser scanning head of ABI 7000 system detects  the accumulation of 
PCR products by analyzing the increase in fluorescence of the reporter dye. The 
TaqMan probes allows simultaneous detection of multiple DNA species (multiplex-
ing) by use of 2 reporter dyes on 2 different probes. By multiplexing, both the tar-
get and endogenous control were amplified in single tube. But for our tests, the 
multiplexing did not work stably as we expected. So all runs were performed us-
ing simplex RT-PCR.
     The threshold cycle or the CT value is determined automaticly by the ABI 7000 
system. For analysis  of the RT-PCR resuslts, the most important parameter for 
quantitation is the CT. Relative gene expression comparisons was carried out by 
using endogenous single copy genes: ROSA26 and GluR-A genes to obtain sta-
ble and constant results. By using an endogenous control as an active reference, 
quantitation of the targets were normalized for differences in the amount of total 
genomic DNA input. Concerning the issue of the choice of a normalizer, work from 
Suzuki et al. (Bio Techniques  2000;29:332) were helpful. Two-step RT-PCR were 
used to perform all RT-PCR experiments. The PCR steps are as following: 94 °C 
Materials and Methods
71
denature for 5 minutes; 94 °C denature for 10 seconds; 60 °C extension for 40 
seconds.  
     All TaqMan primers and probes were designed by following guidelines: 1: The 
Primer Express software designs primers with a melting temperature (Tm) of 58-
600 C, and probes with a Tm value of 100 C higher. The Tm of both primers 
should be equal; 2. Primers should be 15-30 bases in length; 3. The G+C content 
should ideally be 30-80%. If a higher G+C content is unavoidable, the use of high 
annealing and melting temperatures, cosolvents  such as  glycerol, DMSO, or 7-
deaza-dGTP may be necessary; 4. The run of an identical nucleotide should be 
avoided. This is especially true for G, where runs of four or more Gs is not al-
lowed; 5. The total number of Gs and Cs in the last five nucleotides at the 3' end 
of the primer should not exceed two (the newer version of the software has  an op-
tion to do this  automatically). This helps  to introduce relative instability to the 3' 
end of primers  to reduce non-specific priming. The primer conditions are the 
same for SYBR Green assays; 6. Maximum amplicon size should not exceed 400 
bp (ideally 50-150 bases). Smaller amplicons give more consistent results be-
cause PCR is more efficient and more tolerant of reaction conditions (the short 
length requirement has nothing to do with the efficiency of 5' nuclease activity); 7. 
The probes should not have runs of identical nucleotides (especially four or more 
consecutive Gs), G+C content should be 30-80%, there should be more Cs than 
Gs, and not a G at the 5' end. The higher number of Cs produces  a higher DRn. 
The choice of probe should be made first; 8. To avoid false-positive results  due to 
amplification of contaminating genomic DNA in the cDNA preparation, it is  prefer-
able to have primers spanning exon-exon junctions. This way, genomic DNA will 
not be amplified (the PDAR kit for human GAPDH amplification has  such prim-
ers); 9. If a TaqMan probe is designed for allelic discrimination, the mismatching 
nucleotide (the polymorphic site) should be in the middle of the probe rather than 
at the ends; 10. Use primers that contain dA nucleotides near the 3' ends so that 
any primer-dimer generated is efficiently degraded by AmpErase UNG (P/N 
402877). If primers cannot be selected with dA nucleotides near the ends, the use 
of primers with 3' terminal dU-nucleotides should be considered.
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      At the end of each reaction, the recorded fluorescence intensity is used for the 
following calculations: Rn+ is the Rn value of a reaction containing all compo-
nents, Rn- is  the Rn value of an unreacted sample (baseline value or the value 
detected in NTC). DRn is  the difference between Rn+ and Rn-. It is an indicator of 
the magnitude of the signal generated by the PCR.
   There are three methods to quantitate the amount of template: 1. Absolute 
standard method: In this  method, a known amount of standard such as in vitro 
translated RNA (cRNA) is  used, 2. Relative standard: Known amounts of the tar-
get nucleic acid are included in the assay design in each run, 3. Comparative CT 
method: This method uses no known amount of standard but compares the rela-
tive amount of the target sequence to any of the reference values chosen and the 
result is given as relative to the reference value (such as  the expression level of 
resting lymphocytes or a standard cell line).
4.8 Analysis of the endogenous gene of the transgene locus 
4.8.1 Endogenous expression analyzed by in situ hybridization (ISH) with 
oligonucleotide probes
   ISH to brain tissue slices with short (45-80 nucleotides) oligonucleotides was 
developed and optimized by Yong and his collaborators, Lewis, and others (Lewis 
et al., 1985, 1988; Morris et al., 1986; Yong et al., 1986a,b; Yong, 1989; reviewed, 
Wisden et al., 1991; Emson, 1993; Pratt and Kokaia, 1994). Radioactivity labeled 
oligonucleotide probes are popular in ISH and there are many protocol variations. 
Slide-mounted brain sections are cut from unfixed frozen tissue on a cryostat. 
Sections are then fixed with 4% Paraformaldehyde (PFA) and stored in ethanol at 
4 °C until ISH will be performed. Synthetic oligonucleotides are radiolabeled 
(‘tailed’) using terminal deoxyribonucleotide transferase (Roche, Germany) and 
‘hot’ deoxyadenosinetriphosphate ((35S)dATP). The synthetic oligonucleotides is 
diluted to 0.3 pmol/μl before labeling. In our experiments, 0.3 pmol of oligonucleo-
tide (50mers and 55mers) is labeled with 10 pmol (35S)dATP (using a 30:1 molar 
ratio of isotope to oligonucleotide). This results in the addition of approximately 
10-20 AMP residues to the 3’ end of the oligonucleotide (assessed by acrylamide 
gel analysis) (Wisden, W. and Morris, B. J. 2002). For 10 μl reaction: Mix 1 μl oli-
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gonucleotide at concentration of 0.3 pmol/μl; 2 μl 5 x reaction buffer (Boehringer-
Mannheim); 0.6 μl 25 mM CoCl2 (Boehringer-Mannheim); 1.5 μl (35S)dATP (1300 
Ci/mmol, DuPont, NEN, NEG-034H); 5 μl sterile DEPC-treated H2O; 1μl TdT at 
25 U/μl (Boehringer-Mannheim). Incubate for 5-8 min at 37℃. The reaction was 
stopped by adding 40 μl TE buffer (10 mM Tris, 1mM EDTA). To remove the unin-
corporated nucleotides, the total 50 μl from step 3 is applied to a Qiaquick column 
(Qiagen, Germany). The column is spin down briefly, and the flow thru is dis-
carded. Apply 50 μl of elution buffer (Qiagen, Germany) to the column and spin 
down shortly. 2 μl of the eluate is counted by using liquid scintillation counting. 
(the counts should be in the range 50,000 dpm/μl – 200,000 dpm/μl). After count-
ing, 1 μl of 1 M DTT (dithiothreitol; 1 M stock. 3.09 g in 20 ml sterile H2O) is 
added to the eluate to preserve the probes  from oxidation. Labeled probes are 
diluted in hybridization buffer, and the probe-hybridization buffer mix is applied to 
the brain tissue slices, and hybridized overnight at 37℃. The next day excess 
probe is  washed off, and after dehydation, the sections can be exposed to X-ray 
film (Kodak, USA).
4.8.2 Pik3c3 Gene Locus Targeting Vector Construction:  
    Overhang Primers were designed as following: to get >95% restriction enzyme 
digestion efficiency, the end of the overhang primers were designed according to 
NEB catalog. And the overhang nucleotides sequence is  not  longer than 40% 
length of the  oligos used for PCR amplification, regardless of the overall anneal-
ing temperature. We used Long Range PCR amplification kit from ROCHE: Ex-
pand Long Template PCR System (ROCHE 1681 842). The 10.0kb Long Ho-
mologous Arm amplification was  performed as following: Template DNA: BAC 
clone (RP24-185E11) purchased from BACPAC company. And the BAC clone 
was purified by NulearBond Maxi Purification Kit (NuclearBond). For PCR reac-
tion, only tens of nanogram of BAC DNA was used to get specific amplification 
products. Primers were ordered from Thermo Corp. and primers were diluted in 
H2O to 10 pmol/μl for PCR reactions.
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Primer Name Primer sequence
SA87.5-LongArm-5' end AAGGAAGGCCGGCCAAAAGGTATTCTCCTTACGACTCTGTGCTTTCTGCT
GCCAAG
SA87.5-LongArm-3' 
end: 
CACTCAATTCTCATGCAGGACTTCCAGGCCTGAACCTTGTAAGAGTAAGAA
TCAAGGCGCGCCAA
SA87.5-ShortArm-5' 
end: 
GACTAGTGGCCCTCGTGGCCGGCCAATTGGGCCTTGGCGCGCCTTAATTA
AACAGCATGAGTACCGGCAGGGACACAGCAGAGTGTGTAAAGCAAGAATT
GTACAT
SA87.5-ShortArm-3' 
end: 
TTTTCCTTTTGCGGCCGCTTTGTTTAAACGGAGGGGAGGCCACGGGAGG
AAGAGGGTTGGTTAT
    PCR was done in Buffer 3 system (ROCHE, Expand Long Template PCR sys-
tem), which was designed to amplify DNA fragments longer than 12.0kb. and the 
reaction condition is as  following: 2.5 l 10mM dATP; 2.5 l 10mM dCTP; 2.5 l 
10mM dGTP; 2.5 l 10mM dTTP; 1 l 10 mM downstream primer; 1 l 10 mM up-
stream primer;  10xPCR Buffer 3 with MgCl2; 0.75 l Expand Long Template en-
zyme mix (supplied). 
        Thermal cycling program:                
Thermo-Cycles Temperature and Time
-1 cycles: 94°C    2 min
-5 cycles:
94°C    10 sec
62°C    30 sec
    68°C    8 min + 5 sec
-30 cycles:
94°C    10 sec
58°C    30 sec
    68°C    8 min + 5 sec
-68°C for an additional 7 min after the final cycle.
    After PCR reaction, the products were analyzed and purified by 0.7% agarose 
gel (without EtBr, but stained afterwards). Overhang-Primers: Long-arm 3’ & 5’ 
primers; Short-arm 3’ & 5’ primers introduced desired restriction enzyme cutting 
sites: Hind III; Pac I; Afl II; Fse I; Asc I; Pme I; etc.. PCR-amplified ShortArm was 
introduced into backbone plasmid: pHanno’sTK by Hind III  & Not I sites (named 
pShortArmTK). Following that cloning, PCR-amplified-LongArm was cloned into 
Hind III & Fse I linearized pShortArmTK, resulting in plasmid pLongShortArmsTK, 
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which contains the Long- and Short-Arms, and also the Multiple Cloning Sites 
used to clone gene of interests. Before further processes, the homologous arms 
cloned into pLongShortArmsTK were sequenced and analyzed by specific restric-
tion enzymes. Sequencing reactions were performed and sequencing results 
showed that there are no mutations from either the PCR reactions, or cloning pro-
cedures. To clone GFPGluR-A into the targeting constructs, plasmid pnlacZ-
GFPGluR-A(i) was  modified to be compatible with the MCS in pLongShortArmsTK. 
The Backbone of pnlacZ-GFPGluR-A(i) was amplified in two PCR reactions to in-
troduce restriction enzyme sites. The first PCR amplified from PshA I & Hind III 
sites using 5'-End primer (A(i)Backbone01) and 3’-End primer (A(i)Backbone02), 
introducing Asc I and Pac I sites  at the 5’-End and Xba I; Fse I sites at the 3’-End 
and destroying the Pme I  site. The second PCR amplified from AseI-AseI-PshAI 
sites using 5'-End primer (A(i)Backbone03) and 3’-End primer (A(i) Backbone04), 
introducing Xba I site at the 5’-End and Hind III; Ase I; Afl II; Spe I;  Pac I; SgrA I; 
sites at the 3’-End. PCR products  were digested by Xba I and Hind III. The frag-
ments were purified and ligated to generate a plasmid named pBackBone, which 
then was linearized by Afl II  and Pac I, to accept the PCR-Amplified loxP-neo-
loxP element of PGK-neo plasmid. The loxP-neo-loxP element was obtained by 
Overhang-Primers-Mediated (5’pgkneo & 3’pgkneo) PCR reactions, which intro-
duced SgrA I and Pac I sites at the 5’-End; and Afl II site at the 3’-End.  The loxP-
neo-loxP element was digested by Afl II and Pac I, and cloned into plasmid 
pBackBone.
4.9 Targeting in Embryonic Stem Cells.
    Plasmids were digested to linearize about 50 μg plasmids in 330 μl volume and 
then checked 5μl on 1.0% agarose gel. The rest was precipitated by 100% etho-
nal. The pellets were washed and resolved well in 80 μl sterile 1x PBS, then sub-
jected on to Chroma spin 1000TE column for plasmid backbone elimination ac-
cording to manufactural instruction. Change ES medium 2 hours prior to cell har-
vest, the passage number of ES cells was documented with date. Prepare 6 gela-
tine coated plates (10 ml) per electroporation. ES edium was removed completely, 
and washed twice with 5 ml pre-warmed 1x PBS. Add 1.5-2 ml Trypsin, gently 
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shake the plates and incubate 3-5 min. at 37 degree. Suspend cells well (with fire 
polished pasteur pipettes) in 1-2 ml ES medium on the culture dish. Transfer cells 
in 10 ml medium into 15ml Falcon tube and spin 3 min at 1000 rpm RT. Discard 
medium, and re-suspend cells first in 2 ml ES medium with fire polished pasteur 
pipettes, then dilute into 10 ml and plate on one plate. Let feeder cells  settle for 
15 min. at 37 ℃, then wash off ES cells with medium and transfer into 50 ml tube, 
pool cells from multi plates. Check 20 μl suspension under microscope. Count 
cells in 40-50 ml dilution, then spin down, and resolve in 1-1.3x 107/ml cold PBS. 
Put sterile cuvettes on ice, mix 700 μl cells with 100 μl DNA (20-30 μg), transfer 
into cuvette. Leave the cuvette 10 min. on ice.
    After incubation on ice, turn on / off twice the device to unload condensor. Set 
the extender to 500 uF and Capacitance to ‘Ext.’. Set Voltage to 0.24 kVolt. Dry 
cuvettes well before installing. Push both buttons until beep sounds, pay attention 
to the time constance. Double check parameters before putting cuvette for 10 
min. on ice. Turn on/ off twice again when finished. Mix cells  in cuvette and trans-
fer into Falcon tube, add medium to 50 ml, plate out on 5 10 cm plates. Change 
medium after 24 hours. Start administration of G418: 250μg/ml final concentra-
tion, after another 24 hours.
4.9.1 Picking Resistant ES Colonies.
    After selection in G418 containing medium for 8-12 days, cells  on survival con-
trol plate should all be dead. Electroporation plates will have surviving colonies of 
ES cells  which are 0.5-2mm in diameter. These clones are picked for propagation 
and analysis. Plate mitoC treated feeder cells to flat-bottomed 96-well plates on 
the evening before picking. One vial of 4Mio cells  will suffice for two 96-well 
dishes. Use 200 μl medium/well. Change the medium on the clone plates and 
change the medium on the feeder cells  to ES cell medium two hours before pick-
ing. Assemble following materials  in the cell hood: Ppre-warmed PBS and PBS/
PS ( pen/strep, 1x); Pre-warmed ES cell medium in 15 cm culture plate; Round-
bottomed 96-well dish with 50 μl trypsin/PBS (1:1) per well. Multi-tip pipettor (12-
mer); Pipette tips (complete rows of 12). Wash gelatin plate containing clones 2x 
with PBS (after first wash, one can mark easily the position of clones on the bot-
Materials and Methods
77
tom of the plate if necessary) and add 5-8 mls PBS/PS to the plate. Pick the 
clones in to the 96-well plates on row after the other according to the following 
sceme. It’s very helpful to find a personal rhythm and not to interrupt before you 
are finished. Get well organized before one starts. You may either pick in rows of 
twelve or in rows  of eight depending on you speed. Keep in mind that the critical 
step is the trypsin reaction. his  step should produce a single cell suspension by 
should not take for too long. Under the microscope, locate a clone; Lift the lid of 
the plate slightly and approach clone by eye with yellow tip of the pipettman; Un-
der the microscope scrape gently to dislodge the clone from the plate; Suck the 
cells up into the tip, take 50 μl volume maximum, the less, the better; Eject the 
cells into one well of the 96-well plate containing 50 μl trypsin, pipette up and 
down; With a fresh tip, pick the second clone (orientation and clone number is 
easily maintained by relative position of pipette tip taken from rack and analogous 
position of well in 96-well plate); After picking on row (8 clones), pipette up and 
down the mixture in al wells  simultaneously with the multi-tip pipettor; Leave these 
tips  on the pipettor; Pick a second row of eight clones; Again pipette the cells in 
row one up and down with the multi-tip pepettor; Monitor dis-aggregation of ES 
cells u nder the microscope; Stop trypsin reaction by adding 100 μl ES cell me-
dium (from a 15 cm culture dish) to all eight wells  in row one with multi-pipettor 
(fresh tips), pipette up and down; Transfer approximately 2-3 drops to row one of 
96-well feeder cell plate; Pool the remainder of each of the trypsin wells  in row 
one into microfuge tubes; Pools  of 4-12 are convenient, depending on number of 
clones to be picked and analyzed; Store the pools on lice until DNA preparation; 
Continue in this manner to pick clones. Analyze clones as quick as possible in or-
der to minimized the time of growth in the 96-well plates. Propagate the positive 
clones step by step onto laarger plates and freeze as soon as possible; Change 
medium twice a day.
4.9.2 Genomic DNA Extraction from Resistant ES Colonies.
    Expend the positive ES cells in 96-well plate for 2-4 days, then: add 90 μl lysis 
buffer containing 0.5 μl RNaseA solution, incubate the plate at 37 degree for 30 
min. with gentle shaking, sealed with Parafilm. Take out the plate and let it cool 
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down to RoomTemperature. With multi-pipettor pipette up and down 10-12 times, 
then transfer the mixture into 8-mer PCR tubes, containing 30 μl Protein Precipi-
tation Solution. Centrifuge for 10 min, 3000 rpm. About 100 μl Supernatant with 
multi-pipettor into new 8-mer PCR tubes, containing 100 μl Isopropanol (RT) and 
10 ug Glycogen (2μl of 5 mg/ml solution), mix well. Centrifuge for 15 min at 4500 
rpm.  Discard supernatant one row after the other. 200 μl 70% EtOH to PCR 
tubes, and spin at 4500 rpm for 10 min, discard the supernatant. repeat this step 
once more. Dry the PCR tubes in SpeedVaccum for 10 min at 42 ℃. Disolve the 
pellets  in 50 μl sterile H2O, and let it stand on the bench overnight, RT. Check the 
DNA quantity and quality on 1.0% agarose gel.
4.9.3 Preparation of ES Colonies for Blastocytes Injection.
     After selection and identification of correctly targeted ES colonies, the ES cells 
were expanded and frozen at -70℃. Three to five days before injection, three 6 
cm plates with Mito C-Feeder cells were prepared. One day after, the ES cells 
were recovered on 6 cm Feeder cell plates  with three different concentrations, 
which will insure the correct growth rate of recovered ES colonies. On the injec-
tion day, the medium was changed 1-2 hrs before preparation. One to two hours 
later, the plate was washed twice with warm PBS, and added with 1 ml trypsin. 
Trypsinization reaction was monitored every minute under microscope. After 3-8 
minutes, suspend the ES cells with polished plastic pipette carefully. The reaction 
was stopped by adding 1-2 ml medium. ES cells were well suspended in 8 ml 
medium using polished pipettes gently. ES cells were collected by spinning at 
1000 rpm for 5 min at RT. Medium was discarded and ES cells  were resuspended 
in 1 ml ES medium. ES cells were added 4 ml medium and put onto gelatin-
coated 6 cm plate for 20-30 min incubation at 37 ℃. After 30 min incubation, the 
feeder cells were settled on the surface of the gelatin, but the ES cells were 
washed off by gently apply medium on the tilted plate. The washed off ES cells 
were transfered into a new gelatin-coated 6 cm plate. And the procedure was re-
peated 3-5 times, till most of the feeder cells were removed from the medium. Ex-
amine 15 μl ES cells  containing medium under microscope. Collect all the ES 
cells by centrifugation at 1000 rpm for 5 min at RT. Resuspend the ES cells in 1ml 
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ES-Injection-medium (20 μl/ml ES-Medium 1M Hepes (final concentration 20 mM 
) + Pen/Strep) with polished pipette.  ES cells were kept in ice-flake water bath 
and transferred to ZTL-Biotechnology Laboratory in Heidelberg immediately after 
preparation.
 
4.10 Western Blot analysis.
    Pre-chill the homogenizing buffer (1:1=B1:B2, 1/10 Proteinase Inhibitor) on ice. 
Every step will be done in a 4°C cold room. Place the brain tissue into the ho-
mogenizer, and then add 100-300 times (weight of the tissue) homogenizing 
buffer into the homogenizer. Homogenize the brain up and down 4-6 times with 5-
10 strokes each, at 250-500 rpm in a S874 Potter. After homogenizing, transfer 
the solution into a new labeled Eppendorf 1.5 ml tube. Incubate the homogenize 
on ice for 10 min. During incubation, wash the homogenizer with pre-chilled water, 
and dry it with fine tissue paper. After 10 min on-ice-incubation, centrifuge the 
homogenize at 13,000 rpm, 4°C for 10 min. Then transfer and aliquot (3-5 ali-
quots per sample) the supernatant into  new labeled Eppendorf 1.5 ml tubes, 
freeze immediately in liquid Nitrogen and store the aliquots at –70°C.
Buffer Name Chemical Contents pH value
B1 25 mM HEPES pH=7.4.
B2
25 mM HEPES buffer
pH=7.4
  300 mM NaCl
  2% Triton X 100
 Proteinase Inhibitor: 1 mini-tablets in 5 ml H2O 
4.11 Recombinant Adeno Associated Virus (rAAV) as gene delivery system
4.11.1 rAAV Constructs
   pAAV-CMV-nlsitTA was constructed by cloning HindIII and BamHI linearized 
nlstTA of p RK5-htTA+nls into pAAV-MC digested by HindIII and BglII. pAAV-CMV-
nlsrtTA was made by combining HindIII and BamHI linearized nlsrtTA of pRK5-
rtTA+nls into pAAV-MC digested by HindIII and BglII. pAAV-HSYN-nlsrtTA was 
made by three piece ligation: Fragment 1: BlpI and HindIII digested pRK5-
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htTA+nls containing 3’ end nlsrtTA sequence with polyA signal; Fragment 2: 
EcoRI and HindIII linearized pAAV-6pminibi-Sewb; Fragment 3: EcoRI and BlpI 
digested pBS.hM2+nls haboring 5’ end nlsrtTA sequence. pAAV-HSYN-nlsitTA 
was produced by cloning EcoRI and HindIII digested pRK5-htTA+nls containing 
nlsitTA fragment into EcoRI and HindIII linearized pAAV-6p-minibi-Sewb. 
4.11.2 rAAV production and purification:
   After plasmids construction and amplification, rAAVs were produced by calcium-
phosphate cotransfection of Helper plasmids  pDp1, pDp2 and rAAV vector. From 
previous study  and our own laboratory tests, cross-dressing of the rAAV by mix-
ing of two Helper plasmids pDp1 and pDp2 (ratio: 3:1), would increase the purifi-
cation efficiency by using precasted Heparin-Affinity Column (Amersham, Ger-
many), and the cross-dressing will sustain the infection rate of rAAV in neurons. 
Cells  were harvested 72 hours post-transfection. Cells were collected by centrifu-
gation at 4000 rpm, 25℃. Cells were resuspended in Lysis Buffer. After 3 times 
freeze and thaw in dry-ice-ethonal bath, benzonase digestion was incubated at 
37℃ for 45 mins. The crude lysate was centrifuged at 4000 rpm for 30 min at 
25℃. Samples were filtered using low-protein binding filters: 0,45 μm and then 
0,20 μm before loading onto heparin column. After filtration, samples were loaded 
onto heparin column. Flow rate was limited to 2 ml/min. After washing and elution, 
samples were subjected to concentrator (100kd, Millipore, Germany). Virus  stocks 
were concentrated into 0,30 - 1,00 ml from 30,0 ml crude lysate collected from 20 
times 10 cm plate (3x106 cells/plate). For in vivo applications, we adjust the infec-
tious virus concentration to 107-108 particles/ml.
Buffer Name Chemical Contents pH value
Lysis Buffer 150mM NaCl; 50mM Tris; H2O; pH=8.4.
Equilibration and Wash Buffer 1 mM MgCl2; 2,5 mM KCl; PBS; pH=7.2
Elution Buffer 500 mM NaCl; PBS pH=7.2
  
4.11.3 Stereotaxic Injection into the Mouse Brain:
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    Wild-type mice (C57/BL6J or NMRI, aged postnatal day P60) and tTA- ex-
pressin transgenic mice: TgCaMKII-tTA (KT1) (P60); TgCaMKII-NR2C-itTAnls (CN10 and 
CN12) (P60) and Thy1.2-itTA (P60); were anesthetized with i.p. injection of keta-
mine (100 mg/kg) / xylazine (10 mg/kg). Experimental animals  were kept deeply 
anesthetized by monitoring pinch withdrawal, eyelid reflex and respiration rate. 
Heating block (Watlow) was  utilized to maintain the experimental animals’ body 
temperature. Experimental animals were subjected to Stereotaxic Injection using 
the SAS75 stereotaxic alignment system with combination of EM70G manipulator 
(Kopf Instruments, Germany). The three axes: X-axis; Y-axis and Z-axis, were re-
ferred to the medial-lateral axis; the anterior-posterior axis and the ventro-dorsal 
axis, respectively. One to three craniotomies (50-100 μm in diameter) were 
opened on the scull according to coordination map of rodents brain anatomy. Viral 
stock aliquots  (75-100 nl) were delivered carefully using ultrathin (inner diameter 
6-9 μm) glass pipette (Blaubrand intraMARK). All experiments were carried out 
according to the biosafety levels’ guidelines, which are specified in the German 
GenTSV.
4.12 Confocol microscopy:
    Confocal images were obtained using a Zeiss LSM5 PASCAL con-focal laser 
scanning microscope, with a 40x (1.3 NA) oil-immersion objective. Optical slices 
of all specimens were adjusted to 2.0-5.0 mm thick using the Reuse Function of 
Zeiss LSM5 PASCAL. The co-expressed reporter genes were stained using FITC- 
and/or Cy3, to counter stain each other. Images were processed through excita-
tion of an argon laser (excitation, 488 nm; emission, BP505–530 nm emission fil-
ter) for intrinsic Venus signals, and a He-Ne laser (excitation, 543 nm; emission 
filter, LP560 nm) for Cy3-labeled signals. The two co-expressed reporter genes 
were localized in different compartments of the cells: itTA and Cre carry NLS (nu-
clear localization signal); but the Venus is soluble in the cytoplasma. Highly co-
expression patterns were illustrated by merging images from both channels. 
4.13 Live-Imaging using two-photon microscope:
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    TgThy-1.2(64)-itTAnls mice were infected with rAAV-6p-minibiCre-Venus virus as de-
scribed in Materials and Methods. After 5-7 days, the infected TgThy-1.2(64)-itTAnls 
mice were anethetized and the head was fixed. Custom-designed head-plates 
were attached to the injection area after the skull thinned. Fluorescent signals 
were taken and analyzed using ImageJ (http://rsb.info.nih.gov/ij/) and IgorPro 
(Wavemetrics, Lake Oswego, Oregon, United States). Series of images were also 
collected either at frequence rates of 5-15 Hz, or at depths of 50 μm of interval 
with cooled-CCD camera (CoolSnapHQ; Photometrics, Huntington Beach, Cali-
fornia, United States) attached on the custom-built upright fluorescence micro-
scope with a 203, 0.95 NA water immersion objective (Olympus, Tokyo, Japan) 
and the corresponding filter sets (Chroma Technology, Rockingham, Vermont, 
United States): HQ495/30, Q520LP, and HQ545/50 for Venus. The serial pictures 
taken at different time and/or depth interval were transformed into movie and/or 3-
Dimension formats to illustrate the micro-structure mobility upon certain stimuli, 
and to reveal the 3-D structure of infected neurons. 
4.14 Material 
4.14.1 Mouse lines: 
C57BL/6: Fa. Charles River (Deutschland) 
NMRI: Fa. Charles River (Deutschland) 
Thy1.2-itTA: R. Sprengel 
R26R: P. Soriano 
G3: R. Sprengel 
SA87.5: R. Sprengel 
A1.1: R. Sprengel 
Pik3c3-A1: R. Sprengel 
4.14.2 Oligonucleotides Sequences (5’-3’): 
rspCre1 ACCAGGTTCGTTCACTCATGG 
rspCre2 AGGCTAAGTGCCTTCTCTACAC 
Lac3’ TTACCCGTAGGTAGTCACGCA 
Lac5’ TTACGATGCGCCCATCTACAC 
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tTA1: GTGATTAACAGCGCATTAGAGC
tTA4: GAAGGCTGGCTCTGCACCTTGGTG
FP-SA-400: TTCAAGTCTGGATTGCTCTCCTCTCATT
Hgh04: gtgatctacccaccttggcctc
           A(i)Backbone01: cccaagcttgggtaaacgtcgacgaggggtggcatccctgtgacccctc
                                      cccagtgcctct
           A(i)Backbone02:gctctagagcaaggccggccactggtcgagctgatacttcccgtccgcc
                                      aggggacat
           A(i)Backbone03: cccaagcttggattaatcccttaagggactagtcccttaattaaggcacc
                                      ggtgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgctc
                                      ttccgcttcct
            A(i)Backbone04: gctctagagcgtcgagtgaagacgaaagggcctcgtgatac
            5'pgkneo:  gttggccgattcaccggtgccttaattaagggtgagttagctcactcattaggca
                              ccccaggctttacactttatgctt
            3'pgkneo: tttacccaagcttggattaatcccttaagggttacgccagctggcgaaaggggga
                            tgtgctgcaaggcgattaagtt
4.14.3 Antibodies and their dilutions: 
Rabbit polyclonal Anti-Cre (Cre Recombinase), PRB-106C, BabCo; IHC: 
1:3000 
Rabbit polyclonal Anti-tTA/(rtTA) (tetracycline-responsive transactivator; 
and reversed tetracycline-responsive transactivator), PRB-106C, BabCo; 
IHC: 1:3000 
Peroxidase-conjugated Goat Anti-Rabbit IgG (H+L), PI-1000, Vector 
Cy3 dye-conjugated Goat Anti-Mouse IgG (H+L), 115-075-146, Dianova 
Cy3 dye-conjugated Goat Anti-Rabbit IgG (H+L), 111-075-144, Dianova 
Fitc dye-conjugated Goat Anti-Mouse IgG (H+L), 115-095-146, Dianova 
Fitc dye-conjugated Goat Anti-Rabbit IgG (H+L), 111-095-144, Dianova 
4.14.4 Abbreviations: 
α Alpha 
α- Anti 
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AMPA L-a-Amino-3-hydroxy-5-methylisoxazol-4-propionacid
AMPAR AMPA-Receptor ect. -Receptors 
ATP Adenosine-tri-Phosphate
β Beta- 
bp Basepair 
BSA Bovine Serum albumin 
C- Carboxy- 
CaMKII Calsium/Calmodulin-binding ProteinkinaseII 
Ce Cerebellum 
cm Centimeter 
Cre Cre-Recombinase 
CNS Central nervous system
DAB Diaminobenzidine-Hydrochloride 
DNA Deoxyribonucleicacid 
dNTP Deoxynucleoacidtriphosphate
EDTA Ethylendiamintetraacetate 
et al. and others 
g Gram
GFP green fluorescent Protein 
GluR Glutamate-Receptor-Subunit 
h Hour 
H/E Hematoxylin/Eosin 
HEPES N-(2-Hydroxyethyl)piperacin-N-ethansulfanacid 
IHC Immunohistochemstry
i.p. intraperitonal 
kbp Kilobasepair 
kDa Kilodalton 
kHz kiloherz 
LTP Long Term Potentiation 
m Milli 
M Mol 
μ Micro 
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mg Micro Gram
min Minute 
mm Millimeter 
mRNA Messenger-Ribonucleicacid 
n nano 
Neo Neomycin 
NGS Normal Goat Serum 
NMDA N-Methyl-D-Aspartate
NMDAR NMDA-Receptor
NEO Neomycinphosphotransferase 
nt Nucleotide 
NTP Nucleotide-tri-Phosphate 
P Postnatal Days 
pA Polyadenylation signal 
pA Pico Ampere 
PBS Phosphate Buffered Salt solution 
PCR Polymerase Chain Reaction 
pH potential Hydroxyl 
PFA Paraformaldehyde
RNA Ribonukleoacids
rpm Rotate pro Minute 
RT Room temperature 
RT Real-Time 
sec Second 
SDS Sodiumdodecylsulfate
SSC Sodiumchloride-Sodiumcitrate-Solution 
TE Tris/EDTA-Buffer 
TENS Tris-EDTA-Sodiumchloride-SDS-Buffer 
Tg Transgene 
Tris Trishydroxymethylaminomethan 
U Units 
UTR Untranslated Region 
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V Volt 
W Watt 
X-Gal 5-Brom-4-Chlor-3-Indolyl-b-D-Galaktopyranoid 
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